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ABSTRACT 
 
JORDAN THOMAS STOBAUGH: Strategies for Differential Proteomic Analysis by Liquid 
Chromatography-Mass Spectrometry 
(Under the direction of James W. Jorgenson) 
 
 As the field of proteomics has evolved, the analytical techniques used in this field of 
research has also evolved, transitioning from primarily gel-based techniques to separations 
based on liquid chromatography. Enzymatic digestion is often a first step for comprehensive 
analysis, known as bottom-up proteomics, but this comes at a cost of greatly increasing the 
sample complexity. Analysis of intact proteins, or top-down proteomics, is not without 
difficulties either as both the chromatography and mass spectrometry are more challenging. 
Various single and multidimensional techniques have been used to increase the peak capacity 
for bottom-up approaches, as, for the time being, they appear better suited for comprehensive 
proteomic analyses. 
 The focus of Chapter 2 is determining what is possible given commercial 
instrumentation and common analytical methods for a bottom-up analysis. A single- and 
multidimensional separation were compared in the analysis of differentially grown yeast 
samples. These same samples were used in Chapter 3 in a pre-fractionation approach in 
which the intact protein samples were fractionated, then digested. The digested fractions 
were then analyzed by LC/MS to determine protein identity and relative abundance. The 
work presented in Chapter 5 relies on the methods developed in Chapter 3 in the differential 
proteomic analysis of a beta-arrestin 1,2 double-knockout. 
 iv
Lastly, in an effort to increase the number of protein identifications without 
substantially increasing analysis time, new instrumentation was designed to facilitate 
chromatography at pressures not attainable with commercial instrumentation. This was the 
focus of Chapter 4 where a nanoAcquity UPLC was modified for XUPLC operation, 
allowing for an increase in backpressure from 10,000 psi to 40,000 psi. With the increase in 
back pressure, columns with more efficiency either through smaller particle diameters or 
increased length could be used in the analysis of peptide samples. 
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CHAPTER 1: INTRODUCTION AND BACKGROUND FOR PROTEOMICS BY 
MULTIDIMENSIONAL LIQUID CHROMATOGRAPHY MASS SPECTROMETRY 
1.1 Differential Proteomics 
 1.1.1 Definition and Challenges 
Qualitative information was typical of proteomic analyses in early proteomics work 
with much effort being focused solely on the total number of identifications from a given 
sample. Significant improvements in mass spectrometry with much improved data analysis 
tools have contributed greatly to towards the expansion of quantitative approaches and the 
ability to use proteomics for biomarker discovery. The focus of differential proteomics is to 
discern differences in protein expression between samples in an effort to gain additional 
information into the processes that are occurring that would be otherwise difficult to 
ascertain by examining a single sample. The challenges associated with differential 
proteomics are similar to those of any proteomic analysis. The number of proteins possible is 
significant. For example, there are over 5,500 proteins encoded by the yeast genome.1 For 
mammalian cells there are more.2 Expression levels can range from thousands of copies per 
cell down to a few copies with the most interesting proteins often found at the lower end of 
this spectrum.3,4 Cytosolic proteins are typically the easiest proteins to identify based on their 
solubility. Unfortunately, many proteins associated with cell signaling are found to be 
associated with the membrane. Preventing these protein from precipitating and having a 
sample amenable to analysis is a significant challenge.  
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 1.1.2 Approaches: Top-Down vs. Bottom-Up 
 Analysis of intact proteins, top-down proteomics, is a challenging problem both in 
terms of the chromatography and mass spectrometry and is therefore not as common as 
methods involving the analysis of peptides. Identification of proteins through mass alone is 
not a reliable approach for making the identification due to post-translational modifications 
that can alter the molecular weight of the target protein. Therefore, MS/MS of intact proteins 
is required of top-down proteomics. While collision-induced dissociation (CID) is a common 
method of fragmentation, for top-down methods the preferred methods are electron-capture 
dissociation (ECD) or electron-transfer dissociation (ETD).5,6,7 Both of these methods 
provide for a more complete fragmentation of the peptide backbone and tend to retain labile 
post-translational modifications (PTMs). Fourier transform-ion cyclotron resonance (FT-
ICR) mass spectrometers are commonly used for top-down experiments as are a new class of 
mass spectrometers, Orbitraps.8 With resolution in excess of 100,000, both of these 
instruments have the requisite resolution needed to resolve the isotopic charge envelopes of 
co-eluting proteins.5,9,10 Advantages of top-down proteomics include the ability to discern 
isoforms, better characterize PTMs, and better sequence coverage.11 Quantitation of the intact 
protein has also been reported as an advantage of top-down experiments as the protein 
abundance is measured directly and not inferred through peptide intensity.12,13 Despite these 
advantages, there are a number of limitations of this technique that have restricted its 
widespread adoption. The chromatographic challenge of separating intact proteins is 
significant and conditions used for effective protein chromatography, such as the inclusion of 
trifluoroacetic acid (TFA) as an ion-paring agent, hinder electrospray ionization (ESI). 
Peptides, on the other hand, are readily separated without TFA and the use of formic acid to 
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improve ESI does not significantly hinder their separation. One of the key disadvantages of 
top-down proteomics is the need for high-resolution instrumentation and the associated 
expense of such mass spectrometers. Larger amounts of protein are also frequently needed 
and the samples analyzed trend towards simpler mixtures or even purified proteins.8 Some 
recent work has analyzed more complex mixtures by top-down methodology, but fewer 
identifications are possible with current methodologies via top-down proteomics when 
compared to bottom-up approaches.13,14 
As a result of obtaining a greater number of identifications, in addition to the lower 
instrumentation cost, and general experimental simplicity, bottom-up approaches are 
substantially more prevalent for proteomic analyses.8 In a true bottom-up analysis, the intact 
proteins are not subject to an initial separation, but are digested, often by trypsin, and the 
resultant peptide mixture analyzed by LC/MS/MS.8 While sample complexity is greatly 
increased due to the digestion, the chromatography of peptides is less problematic than intact 
proteins. Gradients of water and acetonitrile with formic acid as a modifier are typical of 
peptide separations and can be done on a C18 stationary phase without much in the way of 
special considerations. Though the chromatography is less challenging when attempting to 
resolve peptides with respect to proteins, because there are many more components in the 
mixture, the peak capacity of even the most rigorous separation methods are overwhelmed. 
That said, mass spectrometers offer another dimension of separation and increase the 
effective peak capacity of the analysis.15 This approach holds an advantage over top-down 
methods with regard to proteome coverage, which is an important factor when analyzing 
complex samples.16 Additionally, there is often an increase in sensitivity for bottom-up 
methods over top-down approaches. Much of this advantage is due to the improvement in 
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bioinformatics with significant work being done to improve probabilistic scoring schemes as 
well as incorporation of additional criteria during the searching.17-19 Some of the work has 
been to create libraries of proteomics data to aid in the searching and these efforts are 
onoing.20 Bottom-up approaches, however, suffer from a limited dynamic range and are not 
capable of quantifying across the expression range of proteins in cells. 
There are additional limitations to what can be accomplished through bottom-up 
strategies. Ultimately, peak capacity remains an issue – especially for purely “shotgun” 
samples, where no prior separation has occurred to simplify the sample. While the mass 
spectrometer does provide another dimension of separation, even the most advanced mass 
spectrometers currently available can be overwhelmed by exceedingly complex samples. 
Further improvements to both mass spectrometry and liquid chromatography are needed to 
more deeply examine proteomic samples. Although bottom-up approaches clearly require 
greater peak capacity than presently available in order to better resolve sample components, 
there are additional challenges that require attention. Incomplete sequence coverage, the loss 
of labile PTMs, and an inability to determine the origin of certain peptides as a result of 
redundant sequences are all areas of potential improvement for bottom-up proteomic 
approaches.8 
 1.1.4 Quantitative proteomics 
Much progress has been made with regard to quantitative proteomics in both relative 
and absolute terms. Various labeling schemes have been created to aid in the quantitation. 
Label-free methods are also common. Each approach has certain advantages and limitations 
that make them more suitable for particular proteomic challenges. A common labeling 
strategy that been cited frequently is stable-isotope labeling by amino acids in cell culture 
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(SILAC).21,22 Through the incorporation of heavy and light isotopes in growth media, two 
proteomes can be distinguished from one another based on the mass of the identified peptides. 
Typically, the labeled amino acids used in this approach are lysine and arginine. For the most 
basic of SILAC analyses, one cell culture is grown with a light amino acid while the other is 
grown in heavy amino acid media. By mixing the cells in a 1:1 ratio, any proteins that are 
observed in a 1:1 ratio are known to be equally expressed.  If the ratio is in favor of the light 
amino acid, meaning that a greater intensity of peptides was found from the light amino acid 
culture, then there was a greater expression of that particular protein for the light amino acid 
culture than the heavy. There are a few criteria that must be met in order to be sure of a 
differential identification. The first is that the incorporation of heavy or light amino acids 
must exceed 95%. Another criterion is that the peptides used in the identification, and 
therefore the determination of any associated fold-changes in expression, must have good 
abundance and a good signal-to-noise ratio. Ratios on the order of 1.3-2.0 have been used as 
the minimum cut-off for differential determination.21A key limitation of SILAC is the narrow 
range of samples that can be analyzed by this method. Typically, bacterial or yeast cell 
cultures are used with this method. A significant amount of effort has been placed though on 
creating cell lines with stable-isotope labeling. This has expanded the use of the technique, 
but working beyond controlled cell lines has proven challenging. One group has been able to 
incorporate this labeling method into mice. Initially, this was accomplished by feeding a 
lysine-free diet and providing lysine through alternative means.22 Over a number of weeks, 
the isotope content for a range of cell types analyzed from the mice increased to 
approximately 80%. However, this level of labeling was not enough and extended feeding 
did not help due to recycling of amino acids. Only by breeding mice for several generations 
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and providing a lysine deficient diet for each generation was the incorporation of the label 
able to reach 93%. Other common labeling techniques involve the use of isobaric tags to 
modify peptides allowing for relative and absolute quantitation during tandem mass 
spectrometry.23-25 Protein samples are digested and then tagged with different isobaric tags. 
The two digested protein samples are then combined in equal amounts. During the MS1 scan, 
the tagged precursor ions will not be differentiable, however, the MS2 scan will reveal the 
reporter ions from the tag in addition to the expected fragments. The intensity of these 
reporters can then be compared for quantitative purposes.25 Overall, both chemical and 
metabolic labeling strategies provide for more accurate quantitation of proteins, but the 
expense of the isotopic labels and the limited-scope of available samples discourages 
significant applications. 
Much work has been done to improve the quantitation of protein abundances based 
on the MS signal for label-free methods. The motivation for this type of work is clear. By not 
requiring a label, a much wider range of samples can be analyzed. Integrating peak areas for 
peptides, termed area under the curve (AUC), quantifies proteins based on the intensity of the 
precursor ion. One such method is data-independent acquisition, known as MSE from Waters 
Corporation. All ions are passed to the collision cell and subjected to a high energy scan 
hopefully fragmenting all peptides allowing for sequencing of a greater number of peptides 
than what is possible through data-directed approaches. The MS/MS data is then assigned to 
the precursor ions based on retention time and intensity of the precursor. For quantitation, 
this method relies on the comparison of intensities of the most abundant peptides from a 
given protein to those from a standard of known quantity. Another method for quantifying 
label-free data is through spectral counting. Spectra from peptides assigned to a protein are 
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summed to determine abundance and normalized against a number of factors including the 
length of primary sequence. Studies have indicated that each of these methods produce 
similar findings with regard to protein identifications.26 The data-independent acquisition, 
termed MSE by Waters Corporation, did produce slightly higher sequence coverage and a 
greater number of peptides assigned to proteins on average. The greatest challenge associated 
with label-free techniques, regardless of the quantitation method, lies in the analysis of large 
data sets. Ultimately, as software and MS technology has improved, so has the confidence in 
using label-free techniques for quantitative purposes, and can be considered as a reliable 
alternative to labeling strategies. Detection limits are often reported in the 10fmol to 100pmol 
range with good linearity.27 Already these strategies offer an improvement over classical gel 
approaches with regard to dynamic range, which will only continue to improve with 
advancement in software and instrumentation. This will allow for greater utility in the area of 
biomarker discovery as more is learned regarding entire protein networks involved in 
biological processes. 
1.2. Multidimensional separations for differential proteomics 
 1.2.1 Background and theory 
 It has long been recognized that the peak capacity of single-dimension separations is 
insufficient to completely resolve the components of even modestly complex samples. This 
peak capacity problem is further compounded by the fact that for a random distribution of 
analytes, should the number of components exceed 37% of the peak capacity, significant 
overlapping of peaks will occur.28 Proteomics samples often contain more than a thousand 
proteins or tens of thousands of peptides and even the best single-dimension separations fall 
well short in terms of peak capacity. A multidimensional separation has the ability to 
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dramatically increase the peak capacity and Giddings specified two key criteria for this type 
of separation.29 The first is that, for a separation to be multidimensional, the modes of 
separation must be orthogonal. Many different modes of chromatography have been paired 
for multidimensional separations. Examples include ion-exchange followed by reversed 
phase,30,31 size-exclusion followed by reversed-phase,32,33 and normal-phase followed by 
reversed-phase,34 in addition to others. Altering the sample is another way to achieve 
orthogonality by adjusting the pH of the mobile phase in multidimensional separations. In 
2005, Gilar et al demonstrated the validity of this approach by multidimensional separation 
using reversed-phase chromatography in both dimensions for peptide analysis. In this work, a 
high-pH first dimension was followed by a low-pH second dimension.35 Whichever the 
mechanism, the important point is that the two separation steps must be independent. 
Assuming orthogonal modes between the first and second dimension, the theoretical peak 
capacity of the entire system is simply the peak capacity of the first dimension multiplied by 
the peak capacity of the second dimension. In practice, the peak capacity often falls short of 
the theoretical maximum, but still provides for a significant improvement over most single-
dimension approaches.36  
The second criterion, according to Giddings,28 regarding the operation of 
multidimensional, separations is that the peak capacity of the first dimension must be 
transferred to the second dimension in order for the peak capacities to be multiplicative. 
Sampling the first dimension at a rate of three times the peak capacity is frequently 
mentioned as an appropriate minimum sampling rate needed to preserve the resolution from 
the initial separation.37,38  Often this proves to be impractical, as second dimension run times 
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would need to be exceedingly fast. For more infrequent sampling, the peak capacity of the 
first dimension of separation is reduced to the number of fractions collected. 
The impracticality of sampling the first dimension as frequently as required is most 
notably associated with online methodologies, where the two modes are coupled, although 
there are a number of advantages associated with online approaches.39 Automation is the 
most frequently cited as there is an inherent increase in sample throughput as there is less 
time required on the part of the investigator manipulating the sample and online analyses 
tend to require less time. Also, as there is complete transfer of sample from one dimension to 
the next, sample loss and contamination is significantly reduced. There are significant 
challenges to overcome; however, when implementing an online multidimensional separation. 
Custom instrumentation is often needed, which presents control issues, but more importantly 
are concerns related to the coupling of the LC methods. Mobile phase immiscibility and 
compatibilty is a concern as is the precipitation of salts from buffers. Previous work in the 
Jorgenson lab with online separations of intact proteins addressed these issues by utilizing 
volatile ammonium acetate buffers for anion-exchange chromatography in the first dimension 
and gradients of water and acetonitrile with formic acid for the second.40 These were not the 
ideal mobile phase conditions for either dimension of separation. At a pH of 9.0, the anion-
exchange mobile phase was poorly buffered and the pH would change over the course of the 
analysis. The inclusion of formic acid into the reversed-phase separation was needed to 
improve ionization for the intact mass determination by time-of-flight mass spectrometry, 
whereas TFA would have been preferred for reversed-phase protein separations. 
Offline separations provide an alternative to the more frequently cited online 
multidimensional separations. As for the online approach, there are disadvantages.39 These 
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include, a more labor- and time-intensive approach and an associated difficulty with 
automation as fractions must be collected from the first dimension. There is a greater 
potential for sample contamination so care must be taken to avoid such challenges and 
recovery can be problematic depending on the nature of the analyte. However, despite these 
potential pitfalls, there are significant advantages to an offline separation. Instrumentation is 
very simple. Often all that is needed is an LC pump and a fraction collector. The 
incompatibility of solvents can largely be mitigated as the two modes are no longer directly 
coupled. Most important of all is that the two methods can be independently optimized 
without concern for sampling rates allowing for more flexibility in method development. 
  1.2.2 Two-dimensional gel electrophoresis 
Classically, 2D gel electrophoresis (2DE) was used for differential protein expression 
analysis.41 2DE works by first separating proteins by their isoelectric point utilizing 
isoelectric focusing and then by molecular weight with electrophoresis with both separations 
occurring on a polyacrylamide gel.42 Spots are then excised and the proteins, which are 
digested in gel, are analyzed by traditional chemical sequencing techniques or more 
commonly by MALDI-MS. The resulting accurate mass data can then be compared to a 
database containing enzymatically digested protein sequence information in order to discern 
the identity of the protein, as is done with protein mass fingerprinting. An advantage for this 
method is that it is considered to be among the most rapid methods for identifying protein 
expression differences. However, there are numerous drawbacks rendering it a less than ideal 
method for comprehensive proteomic analyses. A significant drawback is the small dynamic 
range. As a result of the visual procedure needed for identifying differential proteins, only 
proteins of large abundance are observed. Proteins of large abundance are typically not the 
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most interesting for further study. Proteins involved in cell signaling, though, are of great 
interest for a wide variety of research topics and these proteins are often among the least 
expressed.27 In order to analyze these less abundant proteins, further work to enrich the 
sample through fractionation is often needed, resulting in increased analysis time. Increased 
fractionation cannot overcome the inability for hydrophobic proteins, which are frequently 
membrane proteins, to enter the gel.42 This again has implications for the ability to study cell-
signaling pathways as many of the receptors are membrane-associated proteins. Other 
challenges associated with 2DE include difficulty in spot picking and poor resolution of very 
large, small, and very basic proteins. Additionally, interfacing 2DE with mass spectrometry 
is more difficult than methods utilizing liquid chromatography as it requires more sample 
handling and is more labor-intensive than strategies based on liquid chromatography. Despite 
these limitations, proteomics through 2DE has demonstrated promising results with the 
detection of proteins associated with tumors in liver carcinoma, lung adenocarcinoma, 
fibrosarcoma, lymphoma, breast cancer, and prostate cancer.42 Clearly, proteomics, and the 
use of multidimensional separations as part of the workflow, has a profound implication on 
the future of biomarker discovery and should aid in the development of future therapies. 
 1.2.3 Gel-Eluted Liquid-Fraction Entrapment Electrophoresis  
A technique that has become more prevalent recently is gel-eluted liquid-fraction 
entrapment electrophoresis (GELFrEE),43 which uses tube gels to separate proteins. Fractions 
are collected from the outlet of the gels, permitting greater flexibility for downstream 
analysis. The primary advantage for this method of protein fractionation is that the proteins 
do not have to be excised from the gels. As a result of them eluting in solution, there are 
many more possible avenues for analysis available for these samples. After a detergent 
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removal step, intact proteins can be analyzed by FT-MS. The Kelleher group has successfully 
demonstrated this workflow in the analysis of HeLa cells.44 Following the GELFrEE 
fractionation, nano-RPLC-MS was used to identify proteins in the low mass range, up to 12 
kDa.  
While comprehensive proteomics by intact protein analysis with mass spectrometry 
has been somewhat limited owing to challenges associated with ionization of large 
macromolecules, it is not an inherent limitation of the GELFrEE separation. Doucette has 
reported the separation of intact proteins from 10 kDa up to 150 kDa in just over three 
hours.43 Additionally, they observed narrow bands and excellent reproducibility so long as 
the gels were not overloaded. While most of the implementation of this technique has been 
for top-down proteomics, the ability to separate the proteins into narrow, reproducible bands 
is attractive for use in a pre-fractionation strategy. By first separating a sample by MW, a 
single fraction is likely to contain most if not all of the peptides for a given protein. The 
reduction in sample complexity as a result of the fractionation affords bottom-up separations 
a better chance of identifying and quantifying more proteins. 
1.2.4 Multidimensional peptide identification technology 
To overcome the lack of peak capacity associated with bottom-up proteomics, 
numerous strategies involving multidimensional separations have been employed. One of the 
most notable is the multidimensional protein identification technology (MudPIT) approach 
pioneered by Yates for the analysis of peptides.45,46 This method utilizes a biphasic capillary 
column with strong-cation exchange (SCX) as the first dimension and reversed-phase as the 
second dimension of separation directly coupled to a mass spectrometer. These columns are 
prepared by first packing reversed-phase particles into a length of fused-silica capillary 
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followed by packing of the SCX particles. Peptides are eluted step-wise from the SCX 
portion of the column and are subsequently trapped on the reversed-phase half of the column. 
Between each step-wise elution, a revered-phase gradient was employed to elute peptides 
from the column and were analyzed by an LCQ ion-trap mass spectrometer. In order to 
completely analyze their sample of S. cerevisiae, the sample was divided into three parts, a 
soluble fraction and two insoluble fractions. The results of this analysis were the most 
impressive to date and resulted in the identification of 1,484 proteins.45 Additionally, Yates 
determined that the identified proteins spanned all subcellular portions of the cell and that 
they represented a wide variety of proteins in terms of the pI and MW range, abundance, and 
hydrophobicity. For bottom-up proteomics, this method has been successfully employed in a 
wide-range of proteomic challenges. 
1.2.5 Pre-fractionation as alternative MDLC approach 
An alternative approach to either top-down or bottom-up approaches has been 
reported in last few years, but has yet to garner much attention as of yet. The method 
separates intact proteins in the first dimension with fraction collection. These fractions are 
then digested before being subjected to an LC/MS/MS analysis for identity 
determination.47,48 This same approach for proteomic analysis was independently arrived at 
through work in the Jorgenson lab and reached many of the same conclusions offered by 
Martosella et al and Dowell et al.  
In many respects, this type of analysis is analogous to a tandem mass spectrometric 
analysis. In the mass spectrometer, sample is introduced, selected (by mass), fragmented by 
collision-induced dissociation, and the fragments detected and analyzed in order to elucidate 
the identity of the species in question. The liquid chromatographic pre-fractionation approach 
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is quite similar. Sample is injected onto the first column where it is selected based on the 
separation mechanism chosen for this dimension. The fractions containing separated proteins 
are then subjected to a reaction that creates many fragments through enzymatic digestion. 
These fragments are then analyzed in order to determine the identity of the unknown species, 
in this case, proteins. While the MS/MS analysis is clearly an online format and the proposed 
pre-fractionation approach is not, offline multidimensional separations have long been 
considered just that. Many of the earliest examples of multidimensional separations 
demonstrated offline approaches with the first comprehensive two-dimensional technique not 
reported until 1990 by Bushey and Jorgenson.49 One could argue that the pre-fractionation 
approach is also capable of satisfying Giddings criteria for a multidimensional separation. 
The resulting 2D chromatograms from such analyses show peptides scattered widely across 
the available separation space, indicative of orthogonality. The sampling rate needed to 
preserve the peak capacity from the first dimension in order to properly transfer it to the 
second dimension is set by the fraction collection parameters and can be adjusted accordingly 
in order to satisfy the second criterion. 
 To a degree, the precedent for labeling a multidimensional separation for which a 
chemical reaction has modified the sample between chromatographic dimensions was already 
set by Gilar in 2005.35 The previously discussed high/low pH multidimensional peptide 
separations protonate the sample between dimensions. Therefore, between similarities to 
MS/MS analysis and the high/low pH separations, one could safely say that a pre-
fractionation of intact proteins with subsequent digestion and peptide analysis is indeed a 
multidimensional chromatographic technique. Nevertheless, as will be demonstrated in 
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Chapters 3 and 5, the approach serves to increase the ability for investigators to identify and 
quantify proteins, the ultimate goal of any proteomic approach. 
 1.3 Scope of Dissertation 
 In general, a greater emphasis is being placed on improving the introduction of the 
proteomic sample to the mass spectrometer. The scope of work presented here will compare 
current methodology to new methods with the overall goal of improving differential 
proteomics by refining multidimensional separation strategies for both intact proteins and 
peptides. In all cases, spectral counting was used to generate the relative quantitation data 
with the goal of the experimentation to improve the identification of differential proteins. 
Information regarding isoforms and many post-translation modifications will inevitably be 
lost; however, for comprehensive studies presented herein, the goal is to provide basic insight 
into biological processes that could potentially serve as a starting point for a more thorough, 
targeted analysis. 
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CHAPTER 2: BOTTOM-UP ANALYSIS OF S. CEREVISIAE BY UPLC & 2D-UPLC 
2.1 Introduction 
 2.1.1 Bottom-up Proteomics 
 The proliferation of bottom-up proteomics, often termed “shotgun” proteomics, is due 
to the simplicity of the experiment, facilitating improvements in throughput over previous 
methods.1 The simplicity lies in the relatively few number of steps required to prepare the 
sample and perform the analysis. Intact proteins are enzymatically digested, often by trypsin, 
and then analyzed by LC/MS. Alternative approaches involve the use of either 1D or 2D gel 
electrophoresis. With either of these electrophoretic methods, there are significant number 
drawbacks, which were discussed in greater detail in Chapter 1. The two largest reasons for 
moving away from gel electrophoresis is the increased time required on the part of the 
investigator to prepare the sample as well as the associated increase in contamination due to 
the additional steps required. The improved throughput of bottom-up proteomics, allowing a 
greater number of samples to be analyzed in a day, owes itself to the straightforward sample 
preparation procedure as well as the ability to perform separations with peak capacities in the 
low hundreds within a reasonable amount of time.  
 Peak capacities are always insufficient to resolve the components from even modest 
protein digests. Typical peak capacities for the methods allowing the greatest throughput, 
encompassing no more than two hours for an LC/MS analysis, are approximately 300.2 For 
whole-cell lysates, tens of thousands of peptides are present. Many investigators utilizing 
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bottom-up techniques will frequently employ other measures to reduce sample complexity. 
Analysis of a sub-proteome by only digesting proteins from certain organelles is a common 
method for reducing sample complexity.3 Other approaches focus on the removal of the most 
abundant proteins. In human serum, for example, a handful of proteins are responsible for 
more than 99% of the protein present.1 There is little hope of identifying and quantifying 
biomarkers when there is that much protein interference present and depletion strategies are 
particularly well-suited for this type of sample. Dynamic range for bottom-up techniques has 
been reported to be approximately 103.4-6 In complex samples, such as human plasma 
samples, there is an expected range in protein concentration spanning seven orders of 
magnitude, demonstrating a need for further improvements to dynamic range.7 In order to 
increase peak capacity and ideally improve the dynamic range of bottom-up methods, 
multidimensional separations are frequently employed. A number of reviews, in fact, state 
that they are necessary and pay little attention to single-dimension separations of average 
performance.1,3,8,9 While multidimensional separations afford an increase in peak capacity, it 
comes at the cost of analysis time. The previously discussed MuDPIT approach is a favorite 
among proteomics investigators, but does require many hours of analysis.  
 2.1.2 2D nanoAcquity by High/Low pH 
 While the MudPIT technique pioneered by Yates more than 10 years ago has received 
much attention, other multidimensional platforms exist to improve upon the peak capacity of 
single-dimension LC analyses. One method, commercialized by Waters Corporation, utilizes 
a reversed-phase separation for both the first and second dimension. Orthogonality is 
achieved by changing the pH significantly enough between the two dimensions to allow for a 
change in selectivity of the peptides.10 Figure 2-1 shows a diagram of this system for the flow 
 23
paths required during the course of the first and second dimension separations. The first 
dimension is the high pH dimension. In this setup, sample is injected onto the first dimension 
column at a low percentage of organic modifier, typically acetonitrile. Peptides are then 
eluted in stepwise fashion from the first dimension at specific concentrations of acetonitrile. 
The number of fractions is determined by the extent of fractionation desired by the 
investigator. Peptides eluting from the first dimension column must then be diluted with the 
low pH mobile phase with a dilution factor of the aqueous fraction substantial enough to 
cause the peptides to be retained on the trap column. Once an elution step is complete, the 
valve configuration is changed and a gradient of water and acetonitrile at a pH less than 3 is 
run to elute the peptides from the analytical column. 
 The advantage of using such a system is the increase in the peak capacity enabling 
better detection and analysis of the peptides with the convenience of a commercialized 
platform and associated support that accompanies commercial instrumentation. There are, 
however, a number of disadvantages. First, a second UPLC pump must be purchased and 
with additional pumps comes additional maintenance requirements. A second disadvantage 
of this platform is that great care must be taken during method development to properly set 
up the methods. In order to properly determine the elution steps for the first dimension of 
separation, many fractions must be taken in order to determine how many peptides, 
determined via the total ion current, are eluting. This data is then used in conjunction with 
software to determine the “cuts.” Ideally, the second-dimension gradient should be optimized 
for each fraction to achieve the greatest use of the available separation space. Lastly, a 
multidimensional separation requires significantly more analysis time and decreases the 
number of samples that can be analyzed in a given period of time. 
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 2.1.3 Ion mobility in proteomic applications 
 While one way to increase peak capacity of the overall analysis is to incorporate a 
second dimension of chromatographic analysis, another is to increase the peak capacity prior 
to the mass spectrometer. Ion mobility separations (IMS) are gas phase separations that result 
from the difference in drift times due to the difference in velocities of the ions that result 
from their collision with a buffer gas as they are pulled through a drift cell by an applied 
electric field.11 The difference in velocities is due to the variation in the cross-sectional area 
of the molecules. Separation based on shape is somewhat orthogonal to the separation based 
on mass, resulting in an additional separation prior to mass spectrometric analysis. By 
combining IMS-MS with liquid chromatography, three or even four-dimensional separations 
are possible enabling huge peak capacities with peak capacities of 2 x 105 being reported for 
an HPLC-IMS-MS technique.12 With UHPLC instead of HPLC, the peak capacities would 
improve an additional 5-fold owing to the improve resolution of UHPLC over HPLC.2 The 
coupling of this technique with chromatography is efficient as even narrow peaks from 
UHPLC separations are slow with respect to IMS separations. Peaks in UHPLC are often 10 
seconds wide and frequently wider. IMS separations require 10-60 ms while the time 
required to obtain a spectrum from TOF-MS is on the order of 100 μs.12 As a result of the 
difference in timings required for each dimension of analysis, there are more than enough 
data points that can be acquired to properly sample analytes as they elute from the LC 
column. 
 Using liquid chromatography as a mechanism for introducing the greatly simplified 
samples to the mass spectrometer has been shown to decrease detection limits in addition to 
increasing the peak capacity of the analysis. For one study, IMS-MS was compared to LC-
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IMS-MS for peptide analysis. Without the use of chromatography to introduce the sample, 
the limit of detection (LOD) was found to be 40 attomoles. When used in conjunction with 
LC, an LOD of approximately 1 attomole was the result.13  Ion mobility technology is 
commercially available. The type of ion mobility used on one such platform, the Synapt G2 
HDMS platform by Waters Corporation, is traveling-wave ion mobility. The distinct 
advantage of a traveling-wave setup is that the duty cycle of the ion mobility separation does 
not adversely affect the sensitivity of the mass spectrometer.14 An additional benefit further 
improving the sensitivity of this method is the reduction in background ions as a direct result 
of the IMS separations.13  
2.2 Experimental 
 2.2.1 Overview of experimental methods 
 The work presented in this chapter focuses on the ability of commercialized 
instrumentation with commonly used workflows to analyze a complicated sample – whole-
cell lysates from Baker’s yeast. A one-dimensional UPLC separation was conducted with 
Baker’s yeast lysates that were grown differentially – one on dextrose-based media, the other 
on glycerol-based media. The proteins that were identified, and their associated fold-changes, 
were then compared to 2D UPLC methods available using a 2D-nanoAcquity platform. 
Lastly, to assess the effect of improved mass spectrometric analysis, the same one-
dimensional method used to analyze the samples in this chapter with a previous generation of 
mass spectrometer were analyzed by one with an improved detector design and ion mobility. 
2.2.2 Preparation of S. cerevisiae protein extracts 
YAPD and YAPG growth media was prepared by combining 6.0 g of yeast extract, 
12.0 g of Peptone, 12.0 g of glucose or 5 mL of glycerol, 60 mg adenine hemisulfate, and 
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600 mL of water and an additional 10 g bacto-agar for media for the plates. S. cerevisiae 
(BY4741) was the cell line used for analysis. Plates of each growth media were streaked with 
yeast and incubated until sizeable colonies were obtained. This process required two days for 
dextrose and four days for glycerol-based media. A single colony was then used to inoculate 
a 150 mL small-scale culture. These cultures were grown to an O.D. greater than two before 
being used to inoculate a 2 L (in a 4 L flask) prep scale batch. Both the glycerol and 
dextrose-based media samples were harvested when the O.D. was 2.0. For the glyercol-based 
media, significantly more time was required to reach this endpoint. Cells were centrifuged at 
7000g in a Sorvall GS-3 rotor for 30 minutes until pelleted. Cells were then stored at -80°C 
until processed.  
Cells were resuspended by pipet in 2 volumes of 50 mM ammonium bicarbonate with 
protease inhibitors present (Pierce protease inhibitor tablets, 88661) prepared to 
manufacturer’s recommendations. A homogenate was prepared by 8 passes through a chilled 
french press cell dropwise at 20,000 psi. The homogenate was centrifuged (Beckman JA20 
rotor, 30,000 g, 20 min, 4 °C) and a cytosolic fraction was prepared from the cleared lysate 
by ultracentrifugation at 120,000 g for 90 min, 4 °C. Cytosolic fractions were determined to 
be between 10-13 mg/ml of total protein using the Bio-Rad (Hercules, CA) protein assay 
with BSA standard.  Immediately prior to analysis, each fraction was diluted with 25 mM 
ammobium bicarbonate to provide an equivalent protein concentration in all samples. 
 2.2.3 Trypsin digestion of fractions 
Fractions were transferred to microcentrifuge tubes, then lyophilized and 
reconstituted in 25 µL of 50 mM ammonium bicarbonate.  Three microliters of 6.67% (w/v) 
RapiGest™ SF in buffer were added (15 min, 80 ºC) to denature the proteins.  The proteins 
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were reduced by adding 1uL of 100mM dithiothreitol (30 min, 60ºC), and then alkylated with 
1uL of 200 mM iodoacetamide (30 min, room temperature, protected from light).  The 
proteins were then digested by adding 10 µL of 320 ng/µL TPCK-modified trypsin in 50 mM 
ammonium bicarbonate (overnight, 37ºC).  Once the digestion was complete, the RapiGest™ 
SF was degraded using 44 µL of 1% (v/v) trifluoroacetic acid (2 h, 60ºC).  The fractions 
were centrifuged for 20 minutes at 14,000 x g to pellet the hydrolyzed surfactant, after which 
they were ready for analysis. The samples were transferred to sample vials and spiked with 
4.21 µL of a 1 pmol/L internal standard bovine serum albumin digest.   
2.2.5 Capillary UPLC-MS/MS of tryptic peptides 
Each fraction was analyzed using capillary RPLC-MS/MS using a Waters 
nanoAcquity/QTOF Premier system.  The separations were performed on a 250 mm x 75 μm 
ID capillary column packed with 1.7 μm silica bridged-ethyl particles with a C18 stationary 
phase (Waters).  Mobile phase A was Optima-grade water with 0.1% formic acid (Fisher), 
and mobile phase B was Optima-grade acetonitrile with 0.1% formic acid (Fisher).  At a flow 
rate of 300 nL/min, gradients varying in length of 60 to 180 minutes spanning 5-40% 
acetonitrile were used to separate the peptides. Each gradient was followed by a 5 minute 
column wash at 85% B, after which the mobile phase was returned to 5% B.  Two µL of 
sample was injected per run for an average column load of approximately 1 μg of digest 
protein per run. The outlet of the UPLC column was directly connected to an uncoated fused 
silica nanospray emitter with a 20 µm ID and a 10 µm tip (New Objective, Woburn, MA) 
operated at 2.7 kV. Data-independent acquisition, or MSE, scans were performed and the 
instrument was set to perform scans from m/z 50-1990 over 0.6 sec with the collision energy 
alternating between low energy (5.0V), and a high energy ramp (15-40V). 
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2.2.6 Protein identification by PLGS 2.5 & Scaffold 3.3. 
After the MSE data was collected, the mass spectra were processed by ProteinLynx 
Global Server 2.5 (Waters Corporations, Milford, MA) for peptide assignments. Database 
searching and statistical analysis was then completed by importing the sequenced data into 
Scaffold 3.3 (Proteome Software, Portland, OR). To keep the protein false discovery rate to 
approximately 5%, a minimum of 4 peptides, each with a confidence level of 95% were used 
to make the identification of a protein. Two different thresholds were used for protein 
identifications. To assess the chromatography, if a protein was identified with a confidence 
greater than 95% in at least one of three replicate runs, then it was included in the final 
protein count for that set of experiments. A more stringent criterion, however, was applied to 
those proteins used for the differential analysis. In order for a protein to be used in the 
differential comparison, it must have been found in at least two of the three replicate runs at a 
confidence level greater than 95% for a given sample. This was done to allow for Scaffold 
3.3 to perform a Fischer’s exact test on the data and to increase the confidence in the 
differential comparison. 
2.3 Results & Discussion 
 2.3.1 Differential comparison of Baker’s yeast by 1D UPLC. 
 The goal of this study was to determine the effectiveness of commercially available 
instrumentation and software tools for the purpose of making a differential proteomic 
analysis. Baker’s yeast was chosen as it could readily be grown on different carbon sources, 
which one would expect to result in the differential regulation of various metabolic pathways. 
Baker’s yeast is also a moderately complex proteome with approximately 5,500 proteins. 
While one might not consider the methods discussed to be “high throughput,” they do allow 
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for a greater number of samples to be analyzed in a day than more comprehensive techniques, 
which will be discussed in Chapter 3.  
 The shortest single-dimension technique employed utilized a 60-minute gradient for 
an injection-to-injection time of 90 minutes. A total of 58 proteins were found using the 
criterion that a protein must be found in at least two of three replicate runs to be counted as 
an identification for the differential comparison. Figure 2-2 is a Venn diagram of the proteins 
identified by this approach. A total of 30 proteins were identified from the sample containing 
yeast grown on dextrose and 49 from the sample originating from the glycerol media. Of 
these, nine were unique to dextrose, 28 to glycerol, with 21 found in common. These 
numbers, however, do not take into account any statistical analysis regarding whether or not 
they were expressed differentially. Only 31 of the 58 proteins identified were expressed 
differentially as determined by the Fisher’s exact test using a P value <0.05. This was further 
reduced by two to 29 as a result of two of the identifications having a fold-change of less 
than 1.5, the minimum accepted threshold. Table 2-1 lists the differential proteins, their 
associated fold-change, and which sample they were found to be up-regulated in. What can 
immediately be noticed from this is that the majority of the identifications, 23 of 29, were 
considered differential as the identified protein was only found in one of the two samples.  
 Metabolic pathways of interest are shown in Figure 2-3 with proteins identified, but 
not differentially shown in black, those found to be up-regulated in the dextrose sample in 
blue, and those up-regulated in the glycerol sample in red. Proteins not identified, but 
involved in these pathways are shown in bold-face grey type. What can be noticed 
immediately is that very few proteins that were searched for were identified. In fact, only 20 
of 53 proteins were found. Cleary this is the result of the few number of identifications found 
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overall, which is an inherent weakness for this type of analysis. While the digestion is quick 
and easy to do and the separation does not require much time, a significant burden is placed 
on the mass spectrometer and associated software. A total of 1 μg of digested protein was 
loaded onto the trap column for the analysis. Loading greater amounts than this has 
deleterious effects on the chromatography, as peak shapes suffer because of overloading. 
With potentially more than a thousand proteins in the sample spanning several orders of 
magnitude in expression levels, the analysis poses a significant challenge for the mass 
spectrometer, as the peak capacity of the UPLC separation is insufficient to resolve the 
components. In addition to the overall low number of protein identifications, the number of 
peptides used to make the identifications was explored. These numbers varied considerably. 
On average, 8.4 peptides were used in an identification; however, the relative standard 
deviation was 114%. The median value of peptides used to make the identification was found 
to be 7.0 peptides with a high of 27 and a low of 4. Given the large range of expression levels 
possible, this is not an unexpected result. A key, limiting factor in the number of protein 
identifications possible via this approach is the lower limit of detection of the peptides 
needed to make those identifications. 
 For the 60-minute method, glucokinase 1 (HXKG), alcohol dehydrogenase 2 (ADH2), 
aldehyde dehydrogenase 4 (ALDH4), phosphoenolpyruvate carboxykinase (PCKA), malate 
dehydrogenase (MDHM), citrate synthase 1 (CISY1), and succinyl-CoA ligase (SUCA) were 
found to be up-regulated in the glycerol sample.  ADH2 and ALDH4 expression is dextrose 
repressed, therefore their apparent up-regulation in the glycerol sample matches expectations 
as there was no dextrose present.15,16 HXKG is involved in the first irreversible step of the 
metabolism of dextrose and is also found in the cytosol. It is one of three enzymes that S. 
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cerevisiae uses to catalyze the reaction, but it is not responsible for the main role in this 
reaction. It has been demonstrated though, that when shifted to a non-fermentable carbon 
source, such as glycerol, expression of this enzyme increases.17 Malate dehydrogenase is 
involved in the TCA pathway, which during fermentation leads to the formation of organic 
acids.18 This is likely due to the cell’s response to being in glycerol and needing more 
mitochondrial enzymes in order to generate energy.  
During gluconeogenesis, PCKA works to catalyze the reaction of oxaloacetate to 
phosphoenolpyruvate. The process of gluconeogenesis is what allows organisms, such as 
yeast, to grown on carbon sources other than dextrose, such as glycerol. PCKA expression is 
repressed when dextrose is present and is expected to be up-regulated on glycerol, which fits 
with the results from this analysis.19 One enzyme was found to be up-regulated in the 
dextrose sample. This was hexokinase 2 (HXKB). According to the work of Lobo et al, this 
is an expected result as the gene encoding for HXKB is repressed and those encoding for 
HXKA and HXKG are up-regulated when cells are moved to a non-fermentable carbon 
source.20 
 While it was encouraging that the findings from the proteins which were determined 
to be differentially expressed generally matched predictions given the drastic change in 
carbon source, the overall number of protein identifications and the sparse coverage of the 
few metabolic pathways examined demonstrated the limitations of this particular experiment. 
In order to explore the effect of gradient length on the number of identifications and coverage 
of the metabolic pathways, gradients of 90, 120, 150, and 180 minutes were also run in 
addition to the 60-minute gradient. By extending the gradient time, but keeping the flow rate 
constant at 300 nL/min, and the starting and ending points of the gradient (5-40% 
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acetonitrile) consistent, the percent change in the organic modifier across the analytical 
column was reduced for increasing gradient times. It was expected that peak capacity would 
increase to a point and then level off as the maximum separation capability of the column is 
being used, relying less on the gradient at the long times. With increased peak capacity, it 
was believe that there would also be a greater number of identifications. For the 90-minute 
gradient, this was correct, as there was a slight increase in identifications meeting the 
threshold used for differential identifications from 58 to 80. For gradients longer than 90 
minutes, there was little to no improvement observed. The number of identifications for even 
longer methods were 78, 83, and 86 for the 120-, 150-, and 180-minute gradients, 
respectively. For each of the four longer methods, approximately the same number of 
proteins were identified in the dextrose-based sample, the glycerol-based sample, or both 
(Figure 2-4). The number of proteins determined to be actual differential hits based on the 
Fisher’s exact test within Scaffold 3.3 was found to increase from 35 to 45 identifications 
from the 60- to 90-minute gradient lengths. This number remained relatively consistent with 
42, 43, and 47 identifications for the three longest methods. The consistent number of 
identifications is indicative of the maximum peak capacity being achieved with a gradient 
length of approximately 90 minutes. This will be discussed in greater detail in section 2.3.2. 
 With the greater number of identifications made with longer gradients, ideally there 
would be greater coverage of the metabolic pathways of interest to this study. Figures 2-5 
through 2-8 show the pathways and up-regulation of metabolic enzymes for the 90-, 120-, 
150-, and 180- minute gradient lengths. In general, the results from the longer gradients were 
the same as what was previously observed when using the shorter gradient length. HXKA 
was an additional identifications in all four of the longer gradients and was found to be up-
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regulated in glycerol. This data is in agreement with what was previously discussed regarding 
the enzymes involved in this particular process. At the two longest gradient times, there was 
a change in the apparent regulation of HXKB. It was no longer determined to be up-regulated 
in the dextrose sample, and was found to be expressed roughly equally in both samples. The 
scores for HXKB in the glycerol sample were consistent for all the methods. In the dextrose 
sample, it was either not found at all in the 60- and 120- minute gradients. For the 90-minute 
gradient, the counts were low and it was found to be up-regulated in glycerol with a fold-
change of 1.9. A greater score was found for HXKB in the two longer gradients, causing it to 
not be a differential protein as determined by Scaffold 3.3. Another protein of interest that 
was found by increasing the gradient length beyond 90 minutes was glycerol-3-phosphatase 
(GPP1). This enzyme is responsible for the production of glycerol needed for cellular 
processes.21 It was only found in the dextrose sample, which given its role, is not surprising. 
Two other proteins were determined to be up-regulated in the dextrose sample at longer run 
times, phosphoglucose isomerase (G6PI) and phosphofructokinase, subunit alpha (K6PF1). 
According to literature, both of these enzymes are involved in glycolysis, which is the 
process of splitting one molecule of glucose (dextrose) into two molecules of pyruvate with a 
net gain of 2 ATP.22 G6PI converts glucose-6-phosphate to fructose-6-phosphate. K6PF1 
then converts fructose-6-phosphate to fructose 1,6-bisphosphate. 
 2.3.2 Analysis of gradient length and available peak capacity. 
 From the previous section regarding the differential comparison, it is evident that the 
low number of identifications made the task of looking for trends in the up-regulation of 
metabolic enzymes difficult. While the differential proteins that were identified did fall in 
line with expectations from literature, the metabolic pathways of interest were not well 
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covered and there were relatively few additional proteins identified outside of these. 
Extending the gradient from 60 to 90 minutes did result in a nearly 30% increase in 
identifications. Lengthening them beyond this point did little to improve the number of 
identified proteins, although a few additional proteins were able to be identified that were of 
direct interest as they were involved in the targeted processes. As mentioned earlier, this 
would seem to indicate that there were no additional increases in peak capacity when the 
gradients were extended beyond 90 minutes. To examine this possibility further, 
representative chromatograms of the separations are shown in Figures 2-9 and 2-10 for the 
five gradients. Facilitating this analysis, PLGS 2.5 utilizes the Apex3D algorithm, which 
approximates peak shape and determines retention times as part of the data-independent 
acquisition. By examining this data, one can readily find the full-width, half-maximum of the 
peaks fit to a Gaussian. Using the half-height to determine peak width, it was observed that 
peak widths increased from 0.375 minutes to 0.508 minutes with an increase in gradient 
length from 60 to 90 minutes (Figure 2-11). While the peaks were wider in the 90-minute 
analysis, there was an increase in peak capacity from 160 to 180. By extending the gradient a 
further 30 minutes, the peak capacity increased only slightly to 190 and the same peak 
capacity was observed for the 150-minute gradient. At 180 minutes, the peak capacity was 
not able to be calculated from the PLGS data as the peaks had broadened and were tailing 
sufficiently enough that the program was now fitting multiple peaks to a single eluting 
peptide. This caused the apparent peak width to decrease from 0.802 minutes with the 150-
minute gradient to 0.505 minutes, comparable to what was seen with a 90-minute gradient. 
Another complicating factor that was found was the inability for the data acquisition software, 
Masslynx 4.1, to collect data for the entire specified time. For the 180-minute gradient, 210 
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minutes were needed to see the column return to initial conditions. Each of the runs is cut off 
before this point. Upon examination of the data files themselves it was noticed that they were 
all of identical size. The problem is not necessarily related to any of the experimental 
parameters, but is more of a limitation of the software. As Masslynx operates in a 32-bit 
environment, it is unable to collect more than 4 GB of data. Fortunately, with this system 
there is little need to go to these lengths as there was no improvement to the analysis by 
going to analysis times this long. 
 2.3.3 2D nanoAcquity   
As gradient times in excess of 90-minutes did not produce an increase in protein 
identifications and left the coverage of the metabolic pathways of interest with many 
unidentified proteins, a different approach was utilized to try to improve upon these results. 
A multidimensional analysis was implemented to further increase the peak capacity of the 
system beyond the 180-190 peaks possible with a 1D-UPLC system. The high/low pH RP-
RP mode of operation was chosen as it had been shown to have greater orthogonality and 
therefore greater peak capacity than other multidimensional separation formats using the 
nanoAcquity platform. A total of 5 fractions were taken from the first dimension and each 
was subjected to a 30-minute gradient. Figure 2-12 shows the results from this analysis in 
terms of identified proteins. A total of 137 proteins were identified at least once with a 
confidence of 95%. Of those, 63 were found only in the dextrose sample, 27 only in the 
glycerol sample, and 47 found in common between the two samples. A more interesting 
number to look at though, is the number of differential proteins identified after the statistical 
analysis in Scaffold 3.3 was completed. A 1D UPLC separation of varying gradient lengths 
was producing an average of 42 differential identifications, with 45 being identified in the 
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90-minute gradient, which was considered to give the best productivity, identifying 22.5 
proteins per hour. The 2D UPLC separation identified 83 differential proteins, which is 
clearly a significant improvement. In order to get twice the identifications, however, the 
analysis time was increased 3-fold as this analysis requires 6 hours per injection. In terms of 
productivity, this resulted in 13.8 identifications per hour. With the additional identifications, 
one would hope to see an increase in the coverage of the metabolic pathways. Unfortunately, 
as shown by comparing Figure 2-13 to Figure 2-3, this was not the end result. The proteins 
and their relative regulation for the 6-hour long 2D UPLC method was found to be identical 
to the results from the 1D 180-minute method, which was very similar to the other gradient 
lengths. 
 There are a few reasons why this 2D analysis did not result in a significant increase in 
the coverage of the metabolic pathways. Identifying twice the number of proteins sounds 
impressive, but when coupled with the fact that in order to achieve this result the analysis 
time was tripled and the total numbers remain low, this is less impressive. Speaking first to 
the instrumentation, while 6 hours are required of the analysis, much of this time is spent 
equilibrating the analytical column to initial conditions. Time is also spent eluting peptides 
off of the first dimension and onto the second dimension trap column so that they can be 
analyzed by the second dimension column. As a result, a 30-minute long gradient was the 
longest that could be used for an individual step. With five fractions, the total gradient time 
was 150 minutes, an increase of 67%. Given that perspective, identifying twice the proteins 
was an impressive outcome, but unfortunately in order to achieve those results, a substantial 
amount of time had to spent on “housekeeping” tasks. One of the reasons for using the 
high/low pH mode of 2D operation was the improved orthogonality, as demonstrated by 
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Gilar et al, over other 2D formats such as those utilizing strong cation exchange 
chromatography in the first dimension and reversed phase chromatography in the second 
(SCX/RP). Figure 2-14 shows the base peak index (BPI) chromatogram and Figure 2-15 
shows the total ion current (TIC) chromatogram for a representative injection using the 
high/low pH operation. Good intensity for individual peptides was observed as shown from 
the BPI chromatogram, but a general trend of peptides eluting early in the first dimension 
also eluting early in the second dimension can be seen. By examining the TIC chromatogram, 
however, this effect is clearly seen. The first fraction, where 12% acetonitrile was used to 
elute peptides from the first dimension, shows the majority of peptides eluting from 
approximately 10 to 23 minutes. By the time the last fraction is taken, this elution envelope 
shifted out to later retention time and peptides eluted from 20 to 41 minutes. The effect this 
has on the analysis is that the experimental peak capacity falls well short of the theoretical 
maximum, as peptides were not eluting across the entire separation space. In fact, the elution 
envelope from the first dimension represents only 43% of the total gradient time. 
 Subsequent to having the instrumentation configured for a 2D analysis with the 
nanoAcquity UPLC, factors that could have lead to improved performance were determined. 
The choice of which percentage acetonitrile to use for the first dimension fractions were 
based on a visual inspection of the chromatograms after several different possibilities were 
tried. An improved approach would be to run a very detailed fractionation scheme over the 
course of more than a day, eluting peptides at one of two percent intervals. The summation of 
the ions could then be used to create a curve. By fitting an equation to this curve and 
integrating it, even cuts with respect to the total ion count could be achieved. Another 
improvement could be made to the gradients themselves. The same gradient was chosen for 
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each of the five fractions as this had been standard practice for all samples run by UPLC. 
With more method development, the gradients could have been more specifically tailored to 
the peptides eluting in a give fraction. Ultimately, these improvements could result in more 
identifications, but it is doubtful that it would lead to a substantial increase when compared to 
the number of entries in the yeast genome. Even with improvements in gradients and 
fractionation of the peptides, there was still a substantial amount of time spent regenerating 
columns and not collecting data. Chapter 3 discusses improvement to fractionation in 
multidimensional analyses and the work presented in Chapter 4 aims to improve productivity 
by spending less time regenerating columns during an analysis. The single largest 
improvement, which is by far the most expensive and practically difficult to achieve, is to use 
a better mass spectrometer. 
2.3.4 Data from Synapt G2 
Mass spectrometers, like most instrumentation, are constantly being improved upon. 
Occasionally there are significant improvements in performance through the inclusion of new 
technology. The system used to acquire the data presented to this point was a nanoAcquity 
UPLC with a QTOF Premier quadrupole time-of-flight mass spectrometer. While a good 
mass spectrometer with a resolution of 10,000 and an expected sensitivity of 200 counts with 
an 50 pg/uL solution of leucine-enkephalin (Leu-Enk), it is technology from 2004 and is 
prior to a significant advancement in QTOF instrumentation available from Waters 
Corporation. For comparison, the same bottom-up samples were run on a similar system 
under identical LC conditions with the only difference being the use of a Synapt G2 mass 
spectrometer. The expected sensitivity of this instrument is about 10-fold greater than the 
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QTOF-Premier. Additionally, ion mobility is a feature allowing for an even greater peak 
capacity as peptides eluting at the same time can be further differentiated. 
 The gradient chosen for the comparison was the 90 minute gradient as it performed 
the best among the 1D methods explored. A total of 80 proteins were identified with the 
QTOF Premier. When used with the SynaptG2, the number rose to 485 representing a 6-fold 
increase in the number of identifications. Additionally, 295 of these proteins were found to 
be differentially expressed by Scaffold 3.3. Figure 2-16 shows the metabolic pathways that 
were expected to be affected by the different growth media. With better detection, the 
pathways were covered in greater detail. All but three proteins were identified and these were 
not found by any of trials involving different gradient lengths for data collected on the 
Premier. The regulation of proteins found in common between the two techniques were in 
agreement with the exception of HXKB, which was previously mentioned to appear to be up-
regulated in the dextrose sample in shorter gradient lengths, but found to not be differentially 
expressed at longer gradient times. For the data collected on the Synapt G2, it was 
determined to not be differentially expressed. 
 The quality of data was found to be much better from the SynaptG2. Figure 2-17 
shows a histogram of the correct and incorrect assignments for peptides as it relates to the 
peptide score. The higher the peptide score, the more correct assignments one would expect 
to see. Looking at the distribution between the incorrect, shown in blue, and the correct, 
shown in red, one can see that there is a great deal of overlap between the two distributions. 
Effectively, this limits the number of peptides available for assignment as peptides with 
scores below the cutoff are ignored. The false discovery rate (FDR), or the rate at which 
peptides are assigned to the random database appended to the end of the actual database 
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result in false positives, is significantly affected by the peptide score and peptide confidence. 
With the data from the Premier, the peptide confidence had to be set at 95% and a minimum 
of 4 peptides had to be used in order to keep the FDR at approximately 5%. Lowering the 
peptide confidence to allow peptides that were only 90% or reducing the number of peptides 
used for an assignment to three, resulted in a massive increase of the FDR to greater than 
20%. In contrast, data from the SynaptG2, with wider spacing in peptides scores between 
correct and incorrect assignments, allowed these thresholds to be set much lower. The 
peptide confidence could be set as low as 20% and the number of peptides used for an 
identification could be reduced to 2, resulting in an FDR of only 8%. 
2.4 Summary and Conclusions 
 The purpose of this work was to serve as a baseline for comparison for later studies 
involving similar samples. The results from the one-dimensional analysis of the total bottom-
up samples on the nanoAcquity/QTOF-Premier system was not surprising given the lack of 
peak capacity. While throughput is a primary concern for some analytical problems where 
vast numbers of samples need to be analyzed, often looking at a particular analyte, others are 
more concerned with the broad scope of what is in the sample. The protein digests from 
whole-cell lysates fall into the latter category and spending more time on the analysis to 
obtain improvements in the results is worthwhile to the investigator. Increasing the peak 
capacity did serve to improve the number of differential identifications substantially, nearly 
doubling them when a multidimensional separation of the peptides was employed. Ultimately 
the greatest increase in differential identifications was due to the improved results afforded 
by the more advanced mass spectrometric detection. With a 6-fold increase in identifications, 
the metabolic pathways of interest were completely covered. One could argue that if the data 
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collected from the multidimensional peptide separation had been obtained on a SynaptG2, 
that over 700 proteins could have been identified, 500 of them differentially. Later chapters 
will focus on different way to improve the peak capacity of the chromatographic separation 
using the QTOF-Premier for detection. These results should be compared to those obtained 
on the QTOF-Premier with the knowledge that the improved mass spectrometry already 
available commercially could allow for an even deeper look at the proteome. 
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2.6 Tables 
1D UPLC – 60 minute Gradient 
Accession Number Fold Change Up Reg 
ALDH4_YEAST G Only G 
KPYK1_YEAST 1.4 Change<1.5 
ADH2_YEAST 6.9 G 
HSP72_YEAST 1.8 D 
ATPB_YEAST G Only G 
HXKG_YEAST G Only G 
MDHM_YEAST G Only G 
HSP75_YEAST 2.2 D 
ATPA_YEAST G Only G 
OAT_YEAST G Only G 
HSP26_YEAST G Only G 
ALF_YEAST 1.4 Change<1.5 
PCKA_YEAST G Only G 
CISY1_YEAST G Only G 
QCR2_YEAST G Only G 
IF4A_YEAST 2.4 D 
BMH2_YEAST G Only G 
CDC48_YEAST G Only G 
RS7A_YEAST G Only G 
SUCA_YEAST G Only G 
EF2_YEAST 3.5 D 
RIR2_YEAST G Only G 
AHP1_YEAST 3.5 D 
HSP76_YEAST D Only D 
HXKB_YEAST D Only D 
EF1G2_YEAST D Only D 
ACBP_YEAST D Only D 
SYDC_YEAST D Only D 
SNU13_YEAST D Only D 
METE_YEAST D Only D 
OYE2_YEAST D Only D 
 
Table 2-1. Proteins identified as being differentially expressed between the dextrose-based 
and glycerol-based baker’s yeast samples are shown here. These proteins were found to have 
a P-value of less than 0.05 when conducting a Fisher’s exact test. 
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Figure 2-9. Representative chromatograms of the glycerol-based, yeast cell lysate digest for gradient lengths of 60-, 90-, and 120-
minute long gradients. The 60-minute method shows a chromatogram that is crowded with poorly resolved peaks. This improves 
slightly with the 90-minute gradient. A more thorough analysis is needed than what is possible through visual inspection to determine 
improvements to peak capacity. 
53 
 54
 
 
 
 
 
 
 
 
Figure 2-10 Representative chromatograms of the glycerol-based, yeast cell lysate digest for gradient lengths of 150- and 180-minute 
long gradients. For both of these gradients, it does not appear as though the resolution is improving. Peak widths are broader at the 
longer gradient times. A more thorough analysis is needed than what is possible through visual inspection to determine improvements 
to peak capacity. 
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Figure 2-14. These chromatograms are from the multidimensional bottom-up analysis of the dextrose-based yeast sample. The 
chromatograms here show the most intense ion eluting at any given point. Overall intensities were found to be good with 1,500 counts 
being a reasonable value. There is a noticeable correlation between peptides that elute early in the first dimension also eluting early in 
the second dimension. 
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CHAPTER 3: PRE-FRACTIONATION OF DIFFERENTIALLY GROWN S. 
CEREVISIAE CELL LYSATES 
3.1 Introduction 
Complete bottom-up methods for proteomic analysis result in samples that are 
exceedingly complex with regard to the number of components to be analyzed. Further 
complicating the analysis of these samples is the wide-range of expression levels proteins are 
found at within the cell. In order to identify proteins of low abundance, larger injection 
volumes are needed in order to load enough material onto the column so that identifications 
are possible. However, one cannot simply load more sample in many situations without 
deleterious effects. Peptides in large abundance will be overloaded in the case of large 
injections, creating a situation where these peaks begin to saturate the column and detector 
and have pronounced tailing effects resulting in poor resolution of these components. 
Ultimately, the quality of the data from the mass spectrometer suffers resulting in less 
identifications. 
Many different types of multidimensional separations have been employed to increase 
the peak capacity of proteomic samples in an effort to improve the number of identifications. 
The work in this chapter focuses on two pre-fractionation strategies where intact proteins are 
separated and the resulting fractions digested and analyzed in a bottom-up approach. Pre-
fractionation allows for a more comprehensive analysis. Certainly there is an increase in 
analysis time over traditional bottom-up methods, but the increase in peak capacity is needed 
to more thoroughly analyze complicated proteomic samples. Initially, pre-fractionation was 
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completed by anion-exchange chromatography. This method was chosen as it had previously 
been used with some success in both online and offline methodology. The results of this pre-
fractionation scheme were compared to a reversed-phase pre-fractionation approach to 
evaluate the effect of the chromatographic method as it applies to intact protein separations. 
In addition to the comparison between anion-exchange and reversed-phase pre-fractionation, 
the effect of the number of fractions collected during the intact protein fractionation was 
briefly explored as was applying a multidimensional separation at the peptide level resulting 
in three stages of chromatography for the overall analysis. 
3.2. Experimental 
3.2.1 Overview of Experimental Methods 
 A workflow for the experimental methods described here can be found in Figure 3-1. 
Intact protein samples of the cytosolic portion of a yeast cell lysate grown differentially were 
separated by gradient elution by anion-exchange and reversed-phase chromatography. For 
each method, 40 fractions were collected, lyophilized, and digested. All 40 fractions from the 
anion-exchange pre-fractionation approach were initially analyzed by UPLC-MSE. They 
were later combined to form 20 fractions to allow for a comparison with the reversed-phase 
pre-fractionation method where only 20 fractions were analyzed due to analysis time 
considerations. By having an equal number of fractions, a more direct comparison between 
these methods was facilitated. Fractions from the reversed-phase approach were also subject 
to a 2D-UPLC-MSE separation in addition the single-dimension of peptide analysis. All of 
the peptide data was processed by ProteinLynx Global Server 2.5 (PLGS 2.5). Data was then 
exported into Scaffold 3.3 for statistical analysis. 
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3.2.2 Chemicals and sample preparation 
 The chemicals used for the anion-exchange pre-fractionation mobile phases were 
ammonium acetate and ammonium hydroxide purchased from Fisher Scientific (Fair Lawn, 
NJ). Deionized water was purified using a Barnstead Nanopure System (Boston, MA). 
Mobile phases for the reversed-phase pre-fractionation contained Optima™ grade acetonitrile 
and isopropanol, and trifluoroacetic acid, also from Fisher Scientific. Chemicals used for the 
peptide analysis were Optima LC/MS™ grade water and acetonitrile, formic acid, and 
ammonium hydroxide. Chemicals used in the trypsin digestion were: ammonium bicarbonate, 
iodoacetamide and trifluoroacetic acid, purchased from Sigma (St. Louis, MO), RapiGest SF, 
an acid-labile surfactant provided by Waters Corporation (Milford, MA), dithiothreitol 
(Research Products International, Mt. Prospect, IL), and TPCK-modified trypsin (Pierce, 
Rockford, IL). The preparation of the samples used in this analysis was previously described 
in section 2.2.2. 
3.2.3 Intact Protein Pre-fractionation  
The intact proteins were separated by strong anion-exchange and reversed-phase 
chromatography.  The first pre-fractionation separation was performed using anion exchange 
chromatography with a Waters BioSuite Q SAX, 7.5 mm ID x 75mm with 10µm particles 
and 1000 Å pores operated at 50°C.  The mobile phase compositions and gradient profile is 
shown in Table 3-1. A linear gradient from 25 mM to 750 mM ammonium acetate, pH 9.0, 
was run from 0-60 minutes and held at 750 mM until 90 minutes. Two-minute wide fractions 
were collected from 2 to 82 minutes, and every other fraction pooled, yielding 40 fractions. 
Reversed-phase method development utilized two columns. The first column tested 
was a Waters BEH C4 silica-based column containing 1.7 µm particles with 300 Å pores and 
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dimensions of 2.1 mm x 50 mm. This column was operated at 50 °C. A gradient from 15-
50% acetonitrile with 0.2% TFA was employed for the separation. The second reversed-
phase column tested and which was used to a much greater extent was a 4.6 mm ID x 250 
mm PLRP-S column with 5 µm particles (Agilent, Santa Clara, CA). After an initial 
separation, the gradient was changed for improved resolution. Separation conditions for the 
final PLRP-S method can be found in Table 3-2. During fraction collection, one-minute wide 
fractions were collected from 2 to 42 minutes and every other fraction pooled, yielding 20, 
two-minute wide fractions. Fractions were stored at -80º C until lyophilization. 
3.2.4 Protein digestion and Peptide LC-MS/MS  
Fractions were transferred to microcentrifuge tubes, then lyophilized and 
reconstituted in 25 µL of 50 mM ammonium bicarbonate.  Three microliters of 6.67% (w/v) 
RapiGest™ SF in buffer were added (15 min, 80 ºC) to denature the proteins.  The proteins 
were reduced by adding 1uL of 100mM dithiothreitol (30 min, 60ºC), and then alkylated with 
1uL of 200 mM iodoacetamide (30 min, room temperature, protected from light).  The 
proteins were then digested by adding 10 µL of 320 ng / µL TPCK-modified trypsin in 50 
mM ammonium bicarbonate (overnight, 37ºC).  Once the digestion was complete, the 
RapiGest™ SF was degraded using 44 µL of 1% (v/v) trifluoroacetic acid (2 h, 60ºC).  The 
fractions were centrifuged for 20 minutes at 14,000 x g to pellet the hydrolyzed surfactant, 
after which they were ready for analysis. The samples were transferred to LC vials and 
spiked with 4.21 µL of a 1 pmol/L internal standard Bovine serum albumin digest (Waters 
Corporation).   
Each fraction was analyzed using capillary RPLC-MS/MS using a Waters 
nanoAcquity/QTOF Premier system.  The separations were performed on a 250 mm x 75 μm 
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ID capillary column packed with 1.7 μm silica bridged-ethyl particles with a C18 stationary 
phase (Waters).  Mobile phase A was Optima Grade water with 0.1% formic acid (Fisher), 
and mobile phase B was Optima-grade acetonitrile with 0.1% formic acid (Fisher).  At a flow 
rate of 300 nL/min, a 90 minute gradient from 5-40% B was used to separate the peptides, 
followed by a 5 minute column wash at 85% B, after which the mobile phase was returned to 
5% B.  Two µL of sample was injected per run for an average column load of approximately 
1 μg of digest protein per run . The outlet of the RPLC column was directly connected to an 
uncoated fused silica nanospray emitter with a 20 µm ID and a 10 µm tip (New Objective, 
Woburn, MA) operated at 2.7 kV. Data-independent acquisition or MSE scans were 
performed and the instrument was set to perform parent ion scans from m/z 50-1990 over 0.6 
sec at 5.0 V.  The collision energy was then ramped from 15-40 V over the subsequent 0.6 
sec scan. 
3.2.5 Multidimensional LC/MS of peptides 
 Each of the fractions from the reversed-phase pre-fractionation study were also 
investigated by a high/low pH RP-RP-MSE analysis. The first-dimension column was a 150 
µm ID x 150 mm XBridge C18 column with 3.5 µm particles with 130 Å pores. Mobile 
phase A was 25 mM ammonium formate, pH 10.0. Mobile phase B was acetonitrile with no 
ion pairing agent present. The second-dimension column and analytical conditions were the 
same as described in the previous section. Sample loading was increased to 3 µL. The 2D 
with dilution method was operated with a 13:1 dilution factor being applied after the first 
dimension before the trap column of the second dimension using 99.5% water with 0.2% 
formic acid. This ensured that peptides eluting from the first dimension would be trapped for 
second dimension analysis.  Peptides were eluted from the first-dimension in 5 fractions by 
 67
increasing the acetonitrile percentage for each step. Peptides were eluted in steps of 12%, 
16%, 20%, 24%, and 65% acetonitrile. 
3.2.6 Peptide data processing 
The peptide LC-MS/MS data were processed using ProteinLynx Global Server 2.5 
(Waters).  The MSE spectra were searched against a database of known yeast proteins from 
the Uni-Prot protein knowledgebase (www.uniprot.org) with a 1X randomized sequence 
appended to the end. After the database search was complete, the results were imported into 
Scaffold 3.3. (Proteome Software, Portland, OR).  A Fisher’s exact test was performed on the 
triplicate samples.  Proteins with a p-value less than 0.050 between the two yeast samples 
and a fold change greater than 1.5 were considered to be differentially expressed.   
3.3 Results & Discussion 
Previous efforts in our group focused on a hybrid approach of top-down and bottom-
up methodologies involving an online two-dimensional separation of intact proteins by 
strong anion-exchange chromatography followed by reversed-phase chromatography in an 
online format. While those efforts are not the focus of this work, it did serve as the starting 
point for the methods demonstrated here.  Initially, pre-fractionation of intact proteins for 
bottom-up analysis was completed by strong-anion exchange chromatography using the same 
packing material as had previously been used for online analyses. A total of 40, 2-minute 
fractions were collected, digested, and analyzed for the anion exchange fractionation utilizing 
a shallow linear gradient. Initially, all 40 fractions were analyzed requiring more than 240 
hours of analysis time per intact protein sample, as the digested fractions were run in 
triplicate. Subsequent to this analysis, it was determined that for the reversed-phase 
fractionation, every other fraction would be pooled after digestion in order to reduce the 
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analysis time in half, to a more manageable amount. Additionally, each intact protein 
separation was done three times to have replicates from the intact protein separation and not 
just for the peptide separations to more thoroughly evaluate the method. Each of the resulting 
20 reversed-phase peptide samples were then analyzed by UPLC-MSE in two ways. First, 
they were analyzed by a one-dimensional separation and then by a more comprehensive and 
time intensive two-dimensional approach. Lastly, each of the 40 anion-exchange fractions 
were pooled as in the case of the reversed-phase pre-fractionation approach in order to make 
a more straightforward comparison on the basis of gradient fractionation. 
3.3.1 Chromatograms of Intact Protein Separations  
Qualitative results from the UV data (Figure 3-2) of the first dimension provided 
good initial insight without the substantial investment in time required by the digestion and 
bottom-up analysis of each fraction. For both the dextrose- and glycerol-based yeast samples, 
the anion exchange separation exhibited a substantial absorption signal in the UV data at the 
dead time followed by a lull in elution until the ionic strength of the mobile phase had 
increased enough to begin to elute proteins from the column. The large signal occurring at 
the dead time was assumed to be proteins not retained by anion exchange chromatography. 
Fraction collection continued until all proteins were assumed to have been eluted owing to a 
lack of peaks in the UV data and a return to baseline conditions. The observed elution profile 
was not completely unexpected as some proteins will not be bound by the anion-exchange 
resin whereas the majority will and only elute once the gradient increases sufficiently in ionic 
strength to cause a change in the retention. Attempts were made to lower the ammonium 
acetate concentration in order to prevent proteins from eluting in the dead time, however, 
precipitation of the proteins prevented a further reduction in ionic strength and a balance had 
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to be maintained between starting conditions and sample solubility. An initial concentration 
of 25 mM ammonium acetate, pH 9.0, was determined to be an appropriate concentration 
given the constraints. While it is possible that a non-linear gradient could result in a more 
even elution profile, it was believed a further flattening of the gradient during the elution 
window would have only resulted in broader peaks without an increase in resolution. It is 
also possible that conditions could have been ramped more quickly to the point where 
proteins began to elute, however downstream analysis time would not have been significantly 
reduced. The reduction in fractions would have only been by one or two with the additional 
method development requiring a greater investment in time than the bottom-up analysis of 
these few additional fractions. 
Reversed-phase chromatography was explored as an alternative to the anion exchange 
method. Greater resolution for the reversed-phase method was expected as reversed-phase 
chromatography typically yields higher resolution separations than ion exchange for proteins 
owing to the nature of the interactions. After exploring a few different column chemistries, a 
PLRP-S column, comprised of polystyrene-divinyl benzene particles, was selected for use for 
pre-fractionation of intact proteins by reversed-phase. It was chosen over silica-based 
materials due to the rugged nature of the material, allowing for temperatures up to a rated 
maximum of 200°C, which was advantageous when working with protein samples prone to 
precipitation. Columns with silica-based particles were considered for this separation and 
initially, a 2.1 x 50 mm ID XBridge column from Waters with 1.7 um C4 bridged-ethyl 
hybrid particles and 300 Å pores was tried as it is specifically marketed for protein 
separations because of the larger porse size and short alkyl chain length. A gradient of water 
and acetonitrile containing 0.2% TFA was used with a column temperature of 50 °C. 
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Problems were quickly encountered with use of this column as the sample precipitated on 
contact with the inlet frit, clogging this column. In contrast to the previous work with 
elevated temperature RPLC of intact proteins, water/acetonitrile gradients were found to be 
insufficient to prevent protein precipitation.1 Isopropanol as an organic modifier has 
previously been reported to work well with more chromatographically challenging proteins 
because of its greater eluotropic strength and was therefore used in combination with the 
PLRP-S column.2 The new mobile phase B contained 50% isopropanol and 50% acetonitrile 
with 0.2% TFA and the temperature was also increased to 90 °C as elevated temperatures 
have also been reported to improve the resolution of intact protein separations. After the 
sample was injected there was a slight increase in back pressure, however flow was not 
stopped and most proteins were observed eluting in a short window between 30 & 40 
minutes (Figure 3-3). This served as the starting point for further method development, in 
order to better separate the proteins. The gradient used for fraction collection contained an 
initial hold to trap the proteins on the head of the column with a quick ramp to 25%, slightly 
below the gradient strength needed to elute the proteins. The gradient steepness was then 
reduced to allow for the protein separation and ramped at the end to remove any remaining 
proteins. This method provided for separations with almost no ghosting and reproducible 
results as observed by the intact protein separations of both the dextrose and glycerol-based 
yeast separations run in triplicate. The overlay of the replicates for both samples on the PLRP 
column are shown in Figure 3-4. A comparison of the samples by overlaying the UV data 
shows a similar elution profile with regard to intensity and overall chromatographic behavior, 
but definite differences are observed Figure 3-5. 
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Similarly to the anion-exchange method, a substantial signal was observed at the dead 
time in the UV data; however, this did not transition into a long delay and instead peaks were 
observed more consistently throughout the gradient. Furthermore, the resolution of the peaks 
was significantly improved in the reversed-phase separation with many more peaks observed. 
Using a 50:50 mixture of acetonitrile and isopropanol with 0.2% trifluoroacetic acid along 
with elevated temperatures resulted in no ghosting and a consistent back pressure between 
sample and blank runs. Lastly, fraction collection was continued well beyond the last 
observed peak and until the baseline stabilized in an effort to collect as many proteins as 
possible. 
3.3.2 Proteins per fraction 
The most straightforward comparison to make initially is between the two methods 
where the gradient was fractionated evenly for both intact protein pre-fractionation methods. 
It is therefore necessary to start the discussion by comparing the results of fractionating the 
anion-exchange and reversed-phase methods into 20 fractions. A more quantitative look at 
the pre-fractionation strategies was possible once all of the fractions had been digested and 
analyzed by UPLC-MSE.  In Figure 3-6, non-unique protein identifications per fraction were 
represented by the lighter shading in a bar graph for both separations. A non-unique protein 
was defined as any protein found within a given fraction, thus, if a protein were to be found 
in multiple fractions it would be counted in each fraction. The number of proteins found per 
fraction from the anion exchange pre-fractionation mimics the general trends observed from 
the UV data, with proteins found initially followed by a lull and then more identifications, as 
the gradient progressed. In fractions 1 and 2, 34 non-unique proteins were observed whereas 
the following three fractions contained a total of 25 non-unique protein hits. For the reversed-
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phase separation there was again a large UV absorption signal initially, which did not drop 
off as quickly as for the anion-exchange separation, however the results from the protein 
identifications were much different with only 9 non-unique identifications in the first three 
fractions in total. Additional discrepancies between the UV and MS data can be observed, 
demonstrating that UV data is convenient for determining that the separation occurred 
without significant problems, but is not useful for any other conclusions. Another area of 
interest as it relates to the UV data and overall protein identifications occurs towards the end 
of fraction collection. In both pre-fractionation strategies, the UV trace decreased 
significantly over the last five fractions collected.  
If only non-unique protein identifications were taken into consideration, shown in the 
more lightly shaded region of Figure 3-6, it would appear as though fraction collection was 
terminated prematurely in both cases and especially so for the reversed-phase separation, 
which is not suggested by the UV data. However, by also counting a protein only in the 
fraction containing its most intense spectral counts, as determined through Scaffold, it was 
shown that only a small number of proteins were uniquely identified in the last five fractions. 
Had fraction collection been stopped even earlier, reducing the number of bottom-up samples 
and therefore reducing overall analysis time, the overall productivity of the analysis as 
measured in protein identifications per hour, would have been improved. Specifically for the 
reversed-phase separation, fraction collection was terminated after 44 minutes as the baseline 
had stabilized and no peaks were observed after 32 minutes (fraction 15). Fractions 16-20 
only contributed 33 more unique identifications for the reversed-phase separation and only 
16 additional for the anion-exchange pre-fractionation at a cost of 30 hours analysis time per 
method including replicate analysis. In total, there were 784 and 345 unique protein 
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identifications from the reversed-phase and anion-exchange pre-fractionation methods 
respectively, which comprises the data observed in the unique identifications in Figure 3-6. 
Roughly 25% of these proteins were only identified in one of three replicate runs and were 
therefore excluded from any potential differential analysis. For the purpose of a differential 
comparison, a protein must have been identified with a confidence of 95% by Scaffold 3.3 in 
at least two of three replicate runs. With this stricter criterion, the total identifications are 
reduced to 546 and 262 for the reversed-phase and anion-exchange pre-fractionation methods, 
respectively. Of the 262 proteins identified by the anion-exchange method, 220 were found 
to be in common with the reversed-phase method and only 42 found only by anion-exchange 
pre-fractionation, while 326 were found solely by reversed-phase (Figure 3-7). Protein hits 
were counted as a unique identification if found with a confidence greater than 95% by 
Scaffold with a minimum of three peptides, each with a confidence greater than 95%.  
By examining the data from the initial anion-exchange fractionation approach, where 
the 40 collected fractions were digested and each run individually, we can begin to explore 
the effect of gradient fractionation. Increased fractionation has the potential to reduce 
fraction complexity assuming the resolution of the separation mechanism being used, is 
sufficient enough to avoid splitting a given protein across many fractions. However, if 
fractionation is too frequent, then one could potentially expect a decrease in the number of 
identifications as the concentration of each protein would be significantly impacted during 
the digestion step and the peptides needed for identification would be also be spread at lower 
levels across many fractions. The trends observed from the 20 fraction anion exchange 
analysis are also observed for this 40 fraction separation with a substantial number of 
proteins being identified initially and followed by a lull in elution before the rest of the 
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proteins eluted (Figure 3-8). Overall, there were more unique protein identifications by this 
method. By doubling the number of fractions, 370 unique proteins were identified, an 
increase of 41%, with the added cost of doubling the analysis time from 120 to 240 hours, for 
replicate analysis. A Venn diagram demonstrating the overlap in identifications between the 
two anion-exchange methods can be observed in Figure 3-9, with 231 proteins being found in 
common resulting in only 31 proteins being found solely by the AXC20 (anion-exchange 
fractionation with 20 fractions) method. Finding additional proteins unique to the approach 
with fewer fractions is not unexpected. Because the peak capacity of the peptide separation is 
still inadequate to properly resolve all of the components despite pre-fractionation of the 
intact proteins, multiple peptides are eluting at any given time. This is true for both the 20 
and 40 fraction approaches. As a result, occasionally a peptide will be better sequenced, 
seemingly at random, and will result in an identification. This result can also be observed by 
running the same method multiple times. While the majority of the proteins will be identified 
in all replicates, there will be some that are only identified in one or two replicates. A second 
consideration for the additional identifications coming from a method with fewer intact 
protein fractions is in the splitting of the protein peaks as they elute. A protein split between 
two fractions may result in peptides that fall below the limit of detection. By analyzing fewer 
fractions, there are some proteins which will no longer be split and therefore the peptides 
may now be closer to the limit of detection for the mass spectrometer. The AXC40 (anion-
exchange fractionation with 40 fractions) approach with greater identifications overall, 
identified an additional 139 proteins not observed by the less comprehensive approach, albeit 
with increased analysis time. Overall, for these three methods compared, the reversed-phase 
pre-fractionation method provided for the greatest number of protein identifications 
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identifying a large majority of the proteins identified by either anion exchange fractionation 
scheme (Figure 3-10). 
Another option for changing the fractionation scheme is to subject the peptides to a 
multidimensional separation, as was done in Chapter 2 for the differential shotgun analysis of 
yeast. Using the fractions collected from the reversed-phase pre-fractionation strategy, each 
of the 20 fractions from the glycerol pre-fractionation strategy was subjected to a five-
fraction multidimensional analysis. The gradient used during the low pH second dimension 
for this method was 30 minutes in length, increasing the total gradient time per intact protein 
fraction from 90 minutes to 150 minutes. However, the total analysis time per intact protein 
fraction increased from just over two hours to nearly 6 hours as a result of the steps needed to 
re-equilibrate columns. Only the glycerol sample was analyzed by this method and was only 
run once in order to evaluate the merits of this approach. Triplicate analysis of the RP20 
(reversed phase fractionation with 20 fractions) method required 120 hours identifying 415 
proteins in they glycerol sample. This is an equivalent amount of time needed for a single 
analysis by this multidimensional peptide approach. Triplicate analysis for the 2DLC method 
required 360 hours of analysis time. Only 557 proteins were identified by fractionating the 
peptides five times from the first dimension separation in the 2D-RPLC-RPLC method – an 
increase of only 142 new identifications (25%) -- despite a substantial increase in the amount 
of time required (300%) (Figure 3-11). The time during the analysis during which a gradient 
was running and therefore there was potential for peptides to elute for a single 2D analysis 
was 150 minutes as opposed to the 90 minutes of gradient time allowed for the 1D method. 
This results in an increase of gradient time of only 67% as the majority of the time, 210 
minutes, was spent re-equilibrating the system and collecting fractions from the first 
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dimension. Given the modest increase in gradient time, the results are not unexpected. 
Further examination of the chromatograms also shows that the effective use of the available 
gradient space was poor, calling into question the degree of orthogonality of the method 
(Figure 3-12). Additional method development to yield better separations for each step is 
possible; however, flattening the gradient significantly enough to elute the peptides from the 
first step-wise elution across the entire 30 minute gradient window would not likely result in 
a significant improvement in resolution, but broader peaks. 
3.3.4 Fractions per protein 
In order to further evaluate the efficiency of the fractionation, we looked at the 
number of fractions a unique protein was found in and plotted the results for all unique 
proteins from both the anion-exchange and reversed-phase 20 fraction pre-fractionation 
approaches. Looking at raw numbers, there were more unique proteins found in all cases by 
the reversed-phase method. Given that there were more than twice as many proteins 
identified by this method, this is not surprising. When normalized, however, the fractions per 
protein results are consistent across both methods as shown in Figure 3-13. Since the 
majority of proteins, 60% an 61% for reversed phase and anion exchange, respectively, are 
being found in only one fraction, this indicates that the width of each fraction was more than 
sufficient to capture the entire peak as it eluted. Inevitably, proteins will elute during a 
fraction change resulting in a significant number, 20% & 18%, being found in two fractions. 
Somewhat surprising was that 20% of the identified proteins for each pre-fractionation 
method were found spread across three or more fractions, indicating that these proteins were 
eluting over a larger portion of the gradient demonstrating the difficult nature of intact 
protein separations. One possible explanation for this is differences in post-translational 
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modifications, which would change the retentivity of the proteins. This would result in 
peptides used in the identification of a protein being spread across many fractions and would 
require a detailed look at the peptides and associated modifications, if they were present on 
the peptides used in the identification, to determine any differences. 
The results differ only slightly when looking at the other two methods of analysis – 
the AXC40 and multidimensional peptide approaches. With finer fractionation, it was 
expected that proteins would be split more frequently among the fractions and this was case 
with a reduction in the percentage of proteins identified in only one fraction from 61% to 
41%. This was associated with an increase in the number of proteins identified in two 
fractions from 18% to 28%. While the additional fractionation of the anion-exchange 
gradient caused more proteins to be split across fractions, an increase in peak splitting was 
also expected to be detected by the multidimensional peptide separation. This approach has 
previously been reported to yield detection of proteins at lower levels, increasing the 
probability that there would be an increase in the number of fractions a protein was identified 
in. However, when comparing the two peptide analysis methods, one- and two-dimensional 
UPLC, there was only a slight shift towards a greater number of fractions per protein (Figure 
3-14) with the multidimensional peptide method. 
3.3.5 Molecular weight distribution of identified proteins 
The distribution of proteins identified based on molecular weight was another area of 
interest for comparison between the two modes of pre-fractionation. When plotted as a 
histogram with 10 kDa bins from 0-230 kDa, the typical distribution of proteins with the 
majority of the proteins identified between 10 kDa and 40 kDa was observed (Figure 3-15). 
No significant bias was observed as the median molecular weight of proteins identified by 
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the reversed-phase and anion-exchange pre-fractionation methods was determined to be 38.0 
kDa and 37.6 kDa, respectively. Another way to represent this data is to plot the mass of a 
protein against the fraction in which it eluted for all of the proteins identified in order to 
better visualize the results. This provides for a qualitative inspection lending insight into how 
well the gradient space of the first-dimension pre-fraction method is being utilized as well as 
the molecular weight range of identified proteins. The substantial increase in proteins 
identified by the reversed-phase pre-fractionation approach is most evident between10 kDa 
and 40 kDa and can be observed in Figure 3-16. One can also see the increase in the number 
of proteins found by reversed-phase pre-fractionation around the 100 kDa mark. With regard 
to the chromatography, the same general elution patterns can be discerned as observed in the 
UV data, although a drift in molecular weight towards larger proteins was observed between 
fractions 4 and 15 for the reversed-phase separation. Median values for the mass of proteins 
identified by the AXC40 and two-dimensional peptide analysis of the RP20 fractions was in 
agreement with the other two methods with 37.7 kDa and 37.2 kDa for the AXC40 and 
RP20-2D (reversed phase fractionation with 2D peptide analysis), respectively. 
3.3.6 Differential comparison for RP-20 & AXC-20 fractionation strategies 
Three of the methods -- AXC20, RP20, and AXC40 -- analyzed both samples in 
triplicate to allow for a differential comparison of the number of proteins identified per 
sample and the overlap between samples demonstrated in the Venn diagrams. The RP20 
method exhibited better overlap between the dextrose and glycerol yeast samples than either 
of the anion exchange methods with 22% and 34% of the proteins being unique to the 
dextrose and glycerol yeast samples, respectively (Figure 3-17). The AXC20 method, which 
will be the other data set used for the differential comparison below, was found to have a 
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substantially increased number of proteins that could potentially be considered as differential 
proteins (Figure 3-18).  Nearly half of the proteins identified in each sample were uniquely 
identified. A similar trend was observed for the AXC40 method (Figure 3-19).  Upon closer 
examination of the differential proteins, it was observed that for many of these identifications, 
the intensity of these proteins was low, with only a few spectral counts. For proteins 
considered to be differentially expressed, one must question the extent of the differential 
expression for proteins with low spectral counts being identified solely in the glycerol- or 
dextrose-based samples. This is because at the low intensity levels reported, it is possible that 
for the sample where a given protein was not identified, the limit of detection for the analysis 
may play a greater role in the differential classification than what is the result of differences 
in the biological processes. Impacting the limit of detection for the anion-exchange pre-
fractionation strategies is the problem of protein recovery. With proteins likely precipitating 
on the inlet frit of the anion-exchange column, a smaller amount of the sample is making it 
through the system. With less protein in the fractions there would be fewer peptides and 
therefore the limit of detection for the entire analysis would be adversely affected. 
Of the proteins involved in the metabolic pathways of interest, found to be 
differentially expressed, clear trends emerged with regard to the effectiveness of intact 
protein pre-fractionation by the reversed-phase method in comparison to the anion-exchange 
separation. Table 3-3 lists many of these proteins with the average number of peptides used 
in the identification as well as the average coverage percentage as determined by Scaffold for 
both the dextrose and glycerol samples. For the dextrose sample, 21 peptides were found per 
protein on average for the differentially expressed proteins fractionated by reversed phase 
and only 9 for the anion-exchange pre-fractionation strategy with the coverage being 49% 
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and 24%, respectively. A similar trend was observed for the glycerol sample with 27 peptides 
and 59% coverage for the reversed-phase method while only 13 peptides and 36% coverage 
on average from the anion exchange method for the differential identifications. 
Literature shows that growing yeast on different carbon sources effects expression of 
metabolic enzymes.  The differential protein intensities measured by the methods described 
here follows the trends in protein expression predicted by the literature.3  A stronger 
correlation exists between the literature and the results from the reversed-phase pre-
fractionation method than with the anion-exchange pre-fractionation method due to the 
greater number of protein identifications as well as greater intensity as determined by 
spectral counts with the reversed-phase pre-fractionation method.  Several metabolic 
pathways are altered when yeast is grown on glycerol versus its preferred carbon source, 
dextrose.   Glycolysis, gluconeogenesis, glycerol catabolism, glycerolneogenesis, 
fermentation, tricarboxylic acid cycle (TCA), glyoxylate cycle, and pentose phosphate 
pathway will be discussed in more detail (Figure 3-20). 
Glycolysis is the digestion of glucose to pyruvate, which can then be converted into 
energy through the TCA cycle, glyoxylate cycle, or fermentation.  When glucose is not 
present, the cell undergoes gluconeogenesis, which is the formation of glucose from pyruvate.  
Many of the same proteins are involved in glycolysis and gluconeogenesis.  As expected, 
there is no general trend in the differential expression of these proteins as they are active in 
yeast grown on both media sources.  The proteins involved in both these processes were 
identified by both methods.  The one exception is F16P which transforms Fructose-1,6-P to 
Fructose-6-P during gluconeogenesis while K6PF1 is involved in the reverse reaction during 
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glycolysis.  F16P protein was found to be up-regulated in the reversed-phase fractions of the 
glycerol sample, but this protein was not detected in the anion-exchange fractions.   
Analogous to glycolysis and gluconeogenesis are glycerol metabolism, which 
converts glycerol into pyruvate, and glycerolneogenesis, which converts pyruvate into 
glycerol.   For the yeast grown on glycerol, it is predicted that the proteins used in glycerol 
catabolism such as GLPK and GPD1 would be up-regulated4,5 while the proteins used in 
glycerolneogenesis, such as GPP1 and GPP2, would be down-regulated.6  This phenomenon 
is observed in the reversed-phase fractions, but these proteins were not detected in the anion 
exchange fractions.   
After its biogenesis, pyruvate is fermented into ethanol if there is an excess amount of 
glucose present.  A protein complex is formed by PDC1, PDC5 and PDC6.7  This complex is 
involved in the conversion of pyruvate to acetaldehyde during fermentation.  These three 
subunits were detected in the reversed-phase fractions with PDC5 and PDC6 being up-
regulated in the dextrose sample.  Only PDC1 was identified by anion exchange, and it was 
similarly determined to be up-regulated in the dextrose sample.  In the absence of glucose, 
pyruvate enters the TCA or glyoxylate cycle.8  Additionally, any ethanol that may be present 
is converted into acetate to be used in the TCA or glyoxylate cycle.9,5, 10,11,12   
In these pathways, 49 of 52 proteins were identified in the reversed-phase fractions 
with 28 being up-regulated in the glycerol sample, 6 up-regulated in the dextrose sample, and 
15 identified in both, but not differentially.  In the anion-exchange fractions, only 37 of 52 
proteins were identified with 14 being up-regulated in the glycerol sample, 3 in the dextrose 
sample, and 20 identified in both, but not differentially..   Fewer differential proteins were 
observed in the anion-exchange fractions because many of the proteins were lower in 
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intensity and the run-to-run variation was great enough to obscure classification as a 
differential protein.  The metabolic pathways for yeast grown on glycerol occur in the 
mitochondria while fermentation occurs in the cytoplasm.  When looking at the data from the 
reversed-phase pre-fractionation method, our results show that out of 100 mitochondrial 
proteins identified, 37 were up-regulated in the glycerol sample while only 16 were up-
regulated in the dextrose sample.  
The pentose phosphate pathway takes glucose and transforms it into ribulose-5-
phosphate which is used in the formation of ribosomes and subsequently DNA synthesis.  
Cells grown in a glucose deficient environment will break down the ribulose-5-phosphate to 
be used in the TCA cycle.  Therefore, an abundance of ribosomal proteins should exist in the 
yeast grown on dextrose.  Again, using the data from the reversed-phase pre-fractionation, 
the results indicate 32 out of the 55 ribosomal proteins identified were up-regulated in the 
dextrose sample while only 3 were up-regulated in the glycerol sample.   
3.4 Conclusions 
Martosella et al, explored recovery from reversed-phase columns as a function of 
temperature and determined that elevated temperatures, 80°C, were necessary for good 
recovery. While the reversed-phase method utilized a PLRP-S column operated at 80°C, the 
anion-exchange method utilized a BioSuite Q SAX column with an upper temperature limit 
of 50°C, which was employed for the fractionation. With our particular cell lysate, it was 
found that the inlet frit of the anion exchange columns would clog after repeated injections, 
creating a substantial increase in back pressure requiring routine cleaning to maintain them 
and it is likely that a closer look at the anion exchange pre-fractionation would confirm 
recovery as being an issue with this method of pre-fractionation. Clogging of inlet frits was 
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not found to be problematic for the PLRP-S column with no increase in back pressure 
observed after repeated injections. Taking all of this into consideration, protein recovery was 
most likely critically important to the improved performance of the reversed-phase method 
over anion-exchange. An interesting note regarding the inlet frits was determined after the 
pre-fractionation of the intact protein samples had occurred and the peptide workflow was 
well on its way. The Waters BEH300 C4 column was re-examined briefly, and it was found 
that by diluting the sample by at least 50% in 80% formic acid, the sample would remain 
soluble long enough to proceed past the inlet frit of this column. This sample preparation step 
also allowed for subsequent blank runs to remain largely clear of ghosting proteins when 
utilizing this column. 
By fractionating intact proteins, more of the resultant peptides for a given protein are 
contained in fewer fractions as opposed to multidimensional separations at the peptide level, 
providing greater confidence in identifications. Fractionation of intact proteins by either 
anion-exchange or reversed-phase chromatography allowed for greater peak capacity in an 
environment where there is a need as there are approximately 5,500 proteins encoded by the 
yeast genome.13 The reversed-phase method was determined to be particularly powerful as 
temperatures in excess of 80°C were utilized to improve recovery and peak shape and greater 
recovery allowed for greater proteome coverage, which enabled the differential comparison. 
Many of the proteins involved in the metabolic pathways investigated within this work were 
only found by the reversed-phase method. These methods also allowed for milligram 
quantities of protein to be analyzed as opposed to μg quantities common to gel 
electrophoresis-based methods without overloading the first dimension of separation. Greater 
sample loading allowed for greater flexibility with peptide analysis as there was a greater 
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volume of sample available for analysis as well as a greater amount of peptides from less 
abundant proteins, allowing their identification. More importantly, however, is that the 
ability to load a greater amount of protein allows for the possibility of finding proteins of 
lower abundance. 
 With over 120 hours needed to complete the analysis for a single sample and twice 
that in order to make a differential comparison, this method does require a significant 
investment in time. A parameter to be explored in the future and one that is of interest is the 
extent of fractionation required in order to generate useful data. The effect of fractionation 
has been studied previously by many groups and will continue to be studied as there is 
always a balance to be maintained between analysis time and proteome coverage.14 If 
proteins of interest could be identified and quantified by only splitting the intact protein 
separation into 10 fractions, then this would be of great benefit to the investigator. 
Alternatively, owing to the improved resolution of the reversed-phase method, one could 
arguably benefit from increased fractionation, depending on the goals of the investigator. 
What is likely a more prudent method to explore than applying the same fractionation 
scheme to the entire gradient, is to base the fractionation off of the UV data. Areas where 
there is significant signal intensity in the UV data could be more finely fractionated and the 
end of the gradient could be relegated to one large fraction, as there were few new protein 
identifications made during this time, yet a significant amount of analysis time was required 
when evenly fractionating the gradient. 
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3.6 Tables 
 
Time  
 
(min) 
25mM 
Ammonium 
Acetate, pH 9.0 
(%A) 
1M 
Ammonium 
Acetate, pH 
9.0 
(%B) 
0 100 0 
60 0 100 
90 0 100 
90.1 100 0 
 
Table 3-1. Gradient program used for the intact protein pre-fractionation of the yeast cell 
lysates by anion-exchange chromatography. The column used was a Waters BioSuite Q 
SAX, 7.5 mm ID x 7.5 cm with 10 μm particles and 1000 Å pores. The flow rate was 0.5 
mL/min and the column was held at a temperature of 50 °C, the maximum per manufacturer 
recommendations. Forty fractions were collected from 2 to 82 minutes. 
 
 
Time  
 
(min) 
90:5:5 
H2O:ACN:IPA + 
0.2% TFA 
(%A) 
50:50 
ACN:IPA 
+ 0.2% TFA 
(%B) 
0 100 0 
2 100 0 
25 95 5 
40 50 50 
45 35 65 
45.1 0 100 
50 0 100 
50.1 100 0 
 
Table 3-2. Gradient program used for the intact protein pre-fractionation of the yeast cell 
lysates by reversed-phase chromatography. An Agilent PLRP-S, 4.6 mm x 25 cm column 
with 5 μm pores particles and 300 Å pores. The flow rate was 1.0 mL/min. A column 
temperature of 80 °C was used – well below the rated maximum of 200 °C. Fractions were 
collected every minute from 2 to 42 minutes for a total of 40 fractions collected. These 
fractions were later pooled to form the 20 fractions analyzed. 
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  Dextrose  Glycerol 
  Peptides  % Coverage   Peptides % Coverage 
Entry   AXC     RP AXC RP  AXC RP AXC RP 
K6PF1   1.0 26.3 1.6 37.3  0.7 26.7 1.3 34.3 
6PGD1   1.0 32.7 2.9 66.0  7.0 38.0 20.0 77.7 
ACS1   7.3 - 12.3 -  13.3 38.0 24.0 52.0 
ACON   - 8.3 - 13.7  5.7 34.3 11.9 48.7 
ADH1   16.7 25.3 54.0 66.0  17.7 22.3 53.7 65.0 
ADH2   13.7 19.0 30.0 40.7  28.3 38.3 63.0 71.3 
ADH3   - 2.7 1.7 7.2  1.3 4.0 5.7 13.8 
ADH6   1.3 2.7 6.9 14.6  1.7 1.0 8.6 6.1 
ALDH5   - - - -  0.7 3.7 3.9 0.5 
CISY1   - - - -  16.7 26.7 41.0 54.0 
DLDH   2.0 7.3 6.0 23.5  2.0 37.3 7.4 77.3 
ENO1   13.3 20.7 42.0 78.7  15.0 24.7 67.3 78.0 
ENO2   35.7 54.0 57.0 88.3  44.0 51.3 70.3 85.3 
ALF   3.3 30.7 6.9 76.7  9.7 32.7 21.3 71.0 
FUMH   - 1.3 - 3.7  10.3 18.0 34.0 48.0 
FRDS   3.7 10.7 13.0 33.0  10.0 7.7 28.3 22.3 
HXKG   0.7 2.7 1.9 7.8  - 39.0 1.0 71.3 
G6PI   7.0 36.3 19.3 69.0  30.0 37.3 56.3 69.3 
G3P1   10.0 29.0 23.7 52.3  25.3 36.0 63.0 81.0 
G3P2   11.7 24.0 44.3 84.0  13.3 22.3 58.7 85.7 
G3P3   8.0 10.7 71.3 88.0  9.7 10.3 81.7 91.7 
HXKA   4.0 19.0 11.7 54.0  4.7 35.3 13.0 79.3 
HXKB   9.0 33.3 25.7 79.3  10.0 29.3 34.7 81.0 
ACEA   1.7 - 4.0 -  4.0 11.7 8.7 30.3 
ALDH4   12.3 1.7 24.3 4.0  36.3 54.7 66.0 80.7 
MDHC   3.3 - 11.3 2.3  10.7 16.3 35.3 62.7 
MDHM   7.7 6.0 38.0 31.0  21.3 24.0 70.3 71.3 
PCKA   1.0 - 2.5 -  1.7 36.7 3.7 60.7 
PGK   40.0 53.3 77.0 87.0  38.3 49.3 79.3 82.7 
PMG1   13.0 27.0 46.7 80.0  17.3 22.3 66.7 75.3 
PYC1   4.7 6.0 5.7 9.6  6.3 15.0 8.7 19.3 
PDC1   12.3 53.0 19.3 80.0  12.0 47.3 24.3 71.0 
ODPB   1.0 2.7 4.1 8.1  4.7 4.3 14.3 16.3 
KPYK1   32.0 62.0 76.0 87.7  32.3 57.3 75.7 84.0 
SUCA   2.7 13.7 15.1 52.7  15.0 21.7 61.7 82.0 
SUCB   - - - -  2.0 23.7 6.9 46.3 
TKT1   3.0 22.7 7.4 42.7  3.7 24.3 8.9 42.7 
TKT2   - - - -  1.7 5.0 3.1 12.0 
TPIS   11.7 21.3 52.0 85.0  19.7 19.7 86.3 84.7 
                    
Average:  9.2 21.5 24.7 48.6  13.3 26.9 35.6 58.6 
 
Table 3-3. The number of peptides used in an identification as well as the coverage 
percentage of the proteome is shown for both anion-exchange and reversed-phase pre-
fractionation of proteins determined to be involved in the metabolic pathways of interest and 
differentially expressed. Overall, there were more peptides found and a larger coverage 
percentage for the reversed-phase pre-fractionation. 
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Figure 3-2. Anion-exchange pre-fractionation of yeast cell lysates differentially grown on 
dextrose and glycerol-based media. Approximately 4 mg of each sample was inject for 
analysis. The column used was a Waters BioSuite Q SAX, 7.5 mm ID x 7.5 cm with 10 μm 
particles and 1000 Å pores. The flow rate was 0.5 mL/min and the column was held at a 
temperature of 50 °C, the maximum per manufacturer recommendations. A linear gradient 
from 25 mm ammonium bicarbonate, pH 9.0 to 750 mM ammonium bicarbonate, pH 9.0, 
was run from 0-60 minutes with an additional 30 minute hold at 750 mM ammonium 
bicarbonate. Forty fractions were collected from 2 to 82 minutes. For the anion-exchange 
pre-fractionation, the intact protein separation was only done once. 
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Figure 3-3. The initial separation of the dextrose yeast cell lysate on the PLRP-S column, an 
Agilent PLRP-S, 4.6 mm x 25 cm column with 5 μm particles and 300 Å pores. Mobile 
phase A was comprised of 80% water, 10% acetonitrile and 10% isopropanol plus 0.2% 
TFA. Mobile phase A was a 50/50 mixture of acetonitrile and isopropanol with 0.2% TFA 
added. The temperature was held at 90 °C. This gradient was substantially steeper than the 
final gradient conditions used for the pre-fractionation, but demonstrated the utility of this 
column and chromatographic conditions. 
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Figure 3-5. While the samples are very similar and show similar elution trends, there are also 
differences prevalent between the two sample types. The glycerol yeast data, offset by 300 
mAU, show an intense peak at 10 minutes which is missing altogether in the dextrose yeast, 
as an example. The gradient conditions are overlayed in black and correspond to the right 
axis. 
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Figure 3-8. After running all 40 fractions from the anion-exchange pre-fractionation method, 
similar trends are observed as seen previously in Figure 6. The total number of protein 
identifications for each fraction are shown in dark red. Plotting the data in this way is useful 
as it gives an idea as to what is eluting off of the LC column in each fraction and the 
complexity of the sample reaching the mass spectrometer. However, for the purpose of 
determining overall protein identifications, it is more convenient to represent the data by only 
plotting proteins in the fraction of greatest intensity, as determined through Scaffold 3.3, and 
is shown in light red. Finer fractionation where there are large numbers of proteins eluting 
and courser fractionation over portions of the method where there are few unique proteins 
being identified could increase throughput  
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Figure 3-12. A representative set of chromatograms from the reversed-phase fractionation of 
yeast grown on glycerol. Reversed-phase chromatography was used in both dimensions of 
the peptide separation by operating the first dimension at a pH 10 and the second dimension 
at pH 3. The first-dimension column was a custom-packed 150 μm ID x 10 cm XBridge C18 
with 3.5μ particles and 130 Å pores. The second-dimension column was a Waters Acquity 
BEH C18 column with 1.7 μm particles and 130 Å pores. Five fractions were taken from the 
first dimension and peptides were eluted from the first column in five isocratic steps of 12, 
16, 20, 24, and 65% acetonitrile. There is a general trend of peptides eluting early in the first-
dimension also eluting early in the second-dimension suggesting a lack some level of 
correlation between the two dimensions and limiting the peak capacity of the overall system. 
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Figure 3-13. The percentage of unique proteins is plotted as a function of the number of 
fractions a unique protein is identified in. Both anion-exchange and reversed-phase pre-
fractionation strategies exhibit similar behavior when compared on the basis of gradient 
fractionation. The majority of proteins (60%) elute in only one fractions indicating that the 
fractions were approximately equal to the width of a peak. 
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Figure 3-14. Only a slight increase in the number of fractions a unique protein was identified 
in was associated with the more comprehensive peptide analysis. It has been reported that 
greater peak capacity afforded by the multidimensional separation allows for the detection of 
peptides at lower concentrations and therefore the ability to detect proteins at low 
concentration.  
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Figure 3-16. The mass of proteins for the reversed-phase (a) and anion-exchange (b) pre-fractionation methods are shown as a 
function of the fraction each protein eluted in greatest intensity. More abundant proteins are represented by darker bars.  
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CHAPTER 4: XUPLC MODIFICATION OF A NANOACQUITY UPLC 
4.1. Introduction 
4.1.1 Motivation for ultra-high pressure separations 
Many applications in various analytical environments require fast analysis times and 
moderate peak capacities. For these situations there are seemingly endless combinations of 
columns and instrumentation available. Other applications and analytical challenges, such as 
those frequently encountered in metabolomics and proteomics, are somewhat less concerned 
with throughput as with overall peak capacity. Capillary chromatography is well suited for 
high peak capacity analyses in proteomic applications as these can be more readily packed to 
lengths longer than conventional chromatography columns, allowing for greater peak 
capacities.1 Additionally, the small inner diameters of capillary columns consume less 
sample without decreasing the concentration of analytes as they elute from the column, 
making them an ideal choice for samples of limited quantity.2 The nanoAcquity from Waters 
is an instrument commonly used for proteomics applications owing to its ability to provide 
flow down to 100 nL/min allowing for the use of capillary columns of 75 μm in ID. In 
Chapter 2, the performance ceiling in terms of peak capacity for the nanoAcquity system was 
found with an observed experimental peak capacity of approximately 200 and, as shown in 
Figure 4-1, lengthening the gradient beyond 90 minutes did not result in an appreciable 
increase in peak capacity and no increase in protein identifications. Ultimately, more peak 
capacity was desired as the result of the studies in Chapter 2 and not even the 
 110
multidimensional bottom-up analysis had sufficient resolving power for the total bottom-up 
sample analyzed. While the results from Chapter 3 with intact protein pre-fractionation did 
allow for a greater number of proteins identified than by the total bottom-up methods, a 
substantial amount of time was required for this type of analysis. Achieving larger peak 
capacities has been the focus of much work of both single and multidimensional approaches 
for a long time. For single-dimension analyses, the use of smaller particle diameters, longer 
columns, or a combination thereof provides for an increase in peak capacity as a result of the 
increase in theoretical plates.   
Packing such columns on the capillary scale has also been done routinely. MacNair 
and Jorgenson demonstrated the peak capacity possible through one-dimensional capillary 
chromatography in 1997 by packing a 46 cm long column with 1-micron non-porous C18 
particles.1 What allowed this separation was the high pressure available to drive the flow and 
fittings to create low volume connections. By 2004, UHPLC at 100,000 psi was reported.3 
Currently, typical columns used for proteomics applications on the nanoAcquity are 75 
microns in ID with a length of 25 cm packed with 1.9 μm bridged-ethyl hybrid (BEH) n-
octadecylsilyl (C18) particles. Flow rates for these columns are on the order of 300 nL/min 
resulting in backpressures of approximately 8,000 psi, with 10,000 psi as the limit for the 
nanoAcquity. Unfortunately, columns with greater performance either through increased 
length or smaller particle diameters – such as those shown by earlier work in the Jorgenson 
lab – exceed the performance specifications of currently available commercialized 
instrumentation.1,3,4 In order to circumvent the back pressure problem associated with smaller 
particle diameters, some researchers have opted for using more traditional HPLC type 
packing materials, utilizing 5 micron particles packed into columns exceeding a meter in 
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length.5,6 A recent publication demonstrated peak capacities in excess of 1,000 with analysis 
times on the order of 12 hours. Peak widths were reported to be less than a minute wide for 
many of the peptides.7 
 Multidimensional separations have been used extensively to increase the peak 
capacity of an analysis. In concept, the technique is a good fit for proteomic applications, as 
the resulting peak capacities of two orthogonal methods can be quite large owing to the 
multiplicative effect. In practice, multidimensional separations create many challenges. Much 
of the work presented in Chapter 3 relied on the concept of multidimensional separations in 
order to achieve improvements in peak capacity to allow for a more thorough proteomic 
analysis. These techniques focused on offline approaches, considered to be among the most 
time consuming of multidimensional techniques, but with greater flexibility in designing the 
experiment.8,9 For the analysis of peptides, many online techniques have been used for 
proteomic studies with commercialized platforms, such as the high/low pH nanoAcquity 
UPLC described in Chapter 2. These instruments do provide for an increase in peak capacity, 
however, their productivity is hindered by column equilibration after each second dimension 
analysis. Experience using such approaches in this laboratory have found that nearly half of 
the analysis time in a run spanning 6 hours is devoted to such housekeeping tasks with no 
additional information being gleaned. As a result, a high-efficiency single dimension 
separation becomes increasingly attractive as the equilibration time is significantly less.  
4.1.2 Previous prototype instrumentation 
 Prototype instrumentation developed out of collaboration between the Jorgenson lab 
and Waters Corporation facilitated gradient elution for capillary UHPLC.10,11,12 The 
hydraulic amplifier system (Figure 4-2) was routinely operated at 25,000 psi with capabilities 
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to go higher and approach 45,000.10 This system relied on a Waters CapLC system to form 
the gradient and make the sample injection. During the “Load” mode of operation, a gradient 
was formed in reverse and pushed onto the gradient storage loop. The sample was then 
injected and placed at the head of this loop. For “Run” operation, two pneumatically-actuated 
on/off valves from Valco, Inc. were then closed. At this point, the custom instrumentation 
provided the UHPLC conditions. A modified Waters 1525 binary HPLC pump was 
reconfigured to pump DOT3 brake fluid to hydraulic cylinders. Attached to the end of the 
cylinders was a much smaller sapphire plunger, which allowed for the pressure amplification 
at a ratio of approximately 9:1. Therefore, by providing modest HPLC-like pressures from 
the 1525 pump, UHPLC pressures were attainable. The hydraulic amplifiers forced the 
gradient and sample out of the gradient storage loop and onto the analytical column.  
This prototype instrumentation allowed for capillary LC/MS under conditions not 
previously possible and in a completely automated fashion. However, despite the capabilities 
afforded by this approach, the system had several deficiencies. The pump design utilized 
open-loop control for the “constant flow” operation. Constant flow was attempted by 
controlling the flow on the low pressure side of the hydraulic amplifier. The lack of feedback 
often resulted in a measurable difference in flow rates as gradients progressed through the 
column, creating an increase in back pressure as the viscosity of the water/acetonitrile 
mixtures changed over the course of the gradient. The pump heads themselves required 
custom check valves and therefore increased maintenance. Custom software was required 
making use somewhat cumbersome and the system relied on an autosampler not known for 
its efficiency with samples. Lastly, the system, as implemented, used a split flow/split 
injection system without trapping.10 The split flow was required as the flow rates required for 
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the columns utilized was far below the minimum constant flow rate possible. The split 
injection was a result of this need to split flow. Trapping was not originally designed into the 
system and therefore was never utilized with this instrumentation. The system did however, 
provide enough in the way of preliminary results to show what was possible with higher 
pressure pumping capabilities and allowed for testing of many components at these pressures. 
4.1.3 Purpose of nanoAcquity modification 
 There were a number of motivating factors for creating a new system for UHPLC 
operation. Lessons learned from the prototype system were used in the development of the 
XUPLC modification. Design simplicity was a must as the previous system relied on many 
custom parts, which were difficult to replicate and created maintenance dilemmas. An 
emphasis was placed on creating a solution using as many commercially available parts as 
possible. Between simplicity in design and commercial parts, it was hoped that the system 
robustness would be improved. Another motivation behind using off the shelf items was to 
allow for other investigators to more easily adopt this technology, enabling an expansion of 
the technique, whereas the custom instrumentation used before limited this possibility.  
 The autosampler of the nanoAcquity is also more efficient than that of the CapLC 
system. A 1 μL injection on the CapLC would actually consume several microliters of 
sample. With the nanoAcquity, a 1 μL injection consumed 1 μL. The nanoAcquity sample 
manager also was completely enclosed allowing for cooler temperatures. This stands in 
contrast to the open design of the CapLC where the minimum achievable temperature in a 
warm laboratory was no better than 14°C. With the nanoAcquity sample manager, 6° C is 
achievable. 
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4.2 System design & experimental parameters 
 The Waters nanoAcquity UPLC is commonly housed on a cart (Figure 4-3). As part 
of normal operation, the column heater module swings out in front of the mass spectrometer 
source. It was desired to maintain the approximate footprint of the instrumentation as well as 
facilitate the use of the nanoAcquity in its standard configuration once the modification was 
complete. Figure 4-4 shows the completed setup, illustrating that only a modest increase in 
the amount of space required was needed. Additionally, the column heater module of the 
nanoAcquity can still be positioned to allow for normal operation. System design for the 
XUPLC modification was modeled after the trapping operation of the nanoAcquity. Since the 
nanoAcquity is a proven platform, the goal was to attempt to scale up operation with as few 
changes to the operational methodology as possible. There were significant changes required 
as it pertains to routing of transfer lines, additional valves, and software methods. 
Nevertheless, the idea of trapping the sample on a short column, less retentive than the 
analytical column, and then eluting peptides with a gradient and no flow splitting remained at 
the heart of the system. 
4.2.1 Pneumatics 
 Compressed gases, either air or N2, facilitate the operation of high pressure valves as 
well as provide for the driving force for 30,000+ psi operation. A general overview schematic 
of the pneumatics can be seen in Figure 4-5 and Figure 4-6 is a picture showing additional 
details such as the location of ball valves and mounting locations. A convenient way to 
operate the system was through use of a nitrogen gas cylinder. Pressure needed to be 
regulated at the tank to a pressure not exceeding the limitations of the downstream regulators 
– 100 psi was an appropriate amount. Gas flow was then split to provide pressure to each of 
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the downstream regulators, one providing gas to the pneumatic amplifier and the other to the 
pin valves. A ball valve was placed after the tee and prior to the regulator to allow the user to 
quickly shut off gas flow to the high pressure pneumatic amplifier. This was not deemed 
necessary for the pin valve air supply and was not included in the system.  As an additional 
safety precaution, a manual vent in the form of another ball valve was placed after the 
regulator for the pneumatic amplifier to allow for a manual system vent. 
 For the pneumatic amplifier, a high accuracy gauge (0.25% accuracy) was obtained 
from McMaster-Carr. The large dial size is also helpful for the user when specifying the 
pressure for operation as the pressure used during XUPLC operation is manually controlled 
via this regulator and gauge. A direct-acting, 3-way, 2-position solenoid valve (Humphrey 
model 320) with a Cv rating of 1.0 was used to control the gas supply to the pneumatic 
amplifier. A higher Cv rating allows a greater flow rate of gas. It was initially desired to have 
a greater flow rate than provided through this valve, but it was necessary to use this valve as 
larger valves did not meet the necessary pressure range specifications. Ultimately, the 
concern over flow rates was found to not be a problem and the valve used was found 
sufficient for operation of the pneumatic amplifier.  
 The on/off valves from Valco, Inc. are used to manipulate flow paths and isolate 
sensitive components from the high operating pressures. These are pneumatically actuated 
valves, requiring approximately 40 psi to operate. However, they do not require a significant 
amount of flow, therefore exceptionally small pneumatic solenoid valves could be used. 
Valves with a Cv rating of 0.01 (Humphrey model A101x) were used. The manifold 
configuration further simplified plumbing as a single supply line from the regulator could be 
used to provide gas to all the valves.  
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 The pneumatic component that makes the XUPLC modification possible is the 
pneumatic amplifier. A Haskel DSXHF-903 (-903) triple-stage pump obtained from Haskel, 
Burbank, CA, was chosen for operation which has a maximum pressure output of 75,000 psi. 
A convenient consequence of using the -903 is the amplification ratio. At approximately 
1000:1 (actually 1038:1), setting the gas supply pressure becomes easy as one can look at the 
gauge for the regulator and effectively think of the numbers as representing thousands of psi 
on the liquid side, so 30 psi for the inlet pressure corresponds to ~30,000 psi output. 
Additionally, the -903 has a substantial displacement at 2.3 mL. With this amount of 
displacement, the pump should never need to cycle in order to refill during operation, 
providing an even pressure for operation. If the pump were cycling during the course of an 
analysis, it would be expected that retention times would shift as the pressure would fluctuate. 
4.2.2 Fluidic connections 
 An overall fluidic schematic can be seen in Figure 4-7. The modification begins at the 
inject valve of the nanoAcquity, bypassing its built-in second, 6-port valve often referred to 
as the “trapping” valve. Before going into detail regarding the flow paths, it is first important 
to identify many of the key components required for operation. The gradient storage loop 
allows for the nanoAcquity, with its closed-loop pump control, to form a precise gradient and 
store it for use during operation above the nanoAcquity’s limit of 10,000 psi. This gradient 
storage loop is approximately 500 μL in internal volume and is 130’ of 0.005” ID x 1/32” 
OD 316 stainless steel tubing, obtained from Valco Precision Sampling, Baton Rouge, LA 
(TSS.505). Stainless steel ferrules are compression set on the tubing and then brazed with 
silver solder, enabling leak-free connections above 40,000 psi.  
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 Another piece of hardware from Valco enabling XUPLC operation are the UHPLC 
on/off valves (ASFVO40K1). Mentioned earlier in the pneumatics section, these valves work 
by being spring-loaded in the off position. The spring drives a coned piston into a similarly 
coned orifice, closing off the flow path. The valves are opened by the application of 40 psi of 
air, which pushes on a disc and opposes the action of the spring. For operation, four of the 
UHPLC on/off valves are required. Three of these remain in the closed position, while one 
must operate in the open position during the high-pressure operation in order to create the 
correct flow path for elution. Initial operation of the system is limited by the open valve as 
the seal surrounding the piston must hold at 40,000 psi and it is not possible to maintain leak-
free operation above this pressure. Through use of valves with the 10,000 psi limit from 
Valco, it was experimentally determined that if the applied pressure is on the same axis as the 
piston, the valves can form a seal in the closed position and hold at pressures far in excess of 
the rated 10,000. Pressures as high as 30,000 psi were routinely applied to these valves when 
operated in the closed position. Lifetime was likely shortened as a result of operating at these 
pressures and these valves were eventually switched out in place of the 40,000 psi rated 
equipment. A final key piece of hardware from Valco were the microvolume tees 
(MT.5XCS6). Used in four locations, these tees allowed for low volume connections to be 
made under XUPLC conditions. While only rated to 10,000 psi, these two-piece stainless 
steel tees showed no signs of failure after months of use at 30,000 psi. Their internal bore 
was 150 microns. Ideally this bore size would be reduced to reduce effects of extra-column 
broadening and the potential for gradient mixing as both the fused-silica capillary and 
stainless steel tubing were of smaller ID.  
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 An additional component necessary for operation was the column heater, where the 
trap and analytical columns were housed. The temperature control module (TCMII) and 
column heater module (CHM) were provided courtesy of Waters Corporation. While more 
typically used in HPLC as a column heater and mobile phase pre-heater, the size of the heater 
module along with the computer temperature controller was a convenient device for 
providing a constant, elevated temperature for the trap and analytical columns through the 
course of the XUPLC analyses. Lastly, prototype capillary fittings capable of holding at the 
requisite pressures were provided courtesy of Waters Corporation. 
4.2.3 Flow paths 
 For operation, there are three distinct modes, each encompassing a different valve 
state configuration and therefore flow path. These are “gradient loading”, “sample trapping”, 
and “running”. Figure 4-8 shows the flow path for gradient loading with the desired flow 
path shown in green. The valco on/off valves are represented by either red or green circles 
with green showing an open valve and red showing a valve in the closed position. The 
analytical columns used for XUPLC analyses provide a significant amount of flow resistance 
and therefore the flow through the column at the flow rates and pressures observed during 
gradient formation and sample trapping is negligible. During gradient loading, a gradient was 
loaded at a flow rate of 5 μL/min. This was to keep mobile phase A and B under closed-loop 
control as the flow sensors do not provide linear feedback at flow rates in excess of 5 μL/min. 
Gradients are formed in reverse, placing the end of the gradient farther down the gradient 
storage loop as it is a “first on, last off” type of operation. Figure 4-9 demonstrates the flow 
configuration during the second-phase of operation, sample trapping. During sample trapping, 
the gradient storage loop was isolated by closing both the vent and gradient storage isolation 
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valves to prohibit any undesired mixing or additional flow due to mobile phase 
compressibility. The trap valve was then opened to allow flow through the trap column, but 
not through the analytical column. Sample trapping allows for a large volume of low 
concentration sample to be injected onto the system. 
 Once the gradient is loaded and the sample trapped on the trap column, the valve 
states are reconfigured one last time to permit XUPLC operation (Figure 4-10). The vent 
valve, nanoAcquity valve, and trap valve are all closed and the gradient storage isolation 
valve is opened to permit flow from the -903 to the mass spectrometer. Additionally, a 
nanoAcquity vent valve is opened behind the nanoAcquity valve. This additional valve 
serves two purposes. It allows for the nanoAcquity to gradually decrease the flow rate once 
the analysis is commenced and also provides a safety should the nanoAcquity valve fail 
during operation. This would prevent the nanoAcquity from ever experiencing pressures in 
excess of the rated maximum. There is one final safety feature of this system to prevent 
damage to components. The ID of the fused-silica capillary that connects the outlet of the -
903 to the Valco tee at the end of the gradient storage loop is 15 microns in ID. Combined 
with being approximately a meter in length, this capillary line would only permit a flow rate 
of less than 100 μL/min if a catastrophic leak occurred beyond it at 30,000 psi. Additionally, 
during operation, typical flow rates of ~300 nL/min only cause a pressure drop of 100 psi, 
which is 1/3 of 1% of the applied pressure. 
4.2.4 Software interface 
 The previous prototype instrumentation required not only the use of Masslynx for 
LC/MS control, but a significant amount of custom electronics and a custom software 
interface as well. As these custom components began to fail, it created significant problems 
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in the operation of the system. At one point there were three operational hydraulic amplifier 
prototypes, which has since been reduced to one, and the functionality of that system is only 
possible because of a workaround. Thus, when designing the present system, it was desired 
to use the built-in functionality of the control software provided by Waters Corporation with 
a nanoAcquity UPLC/MS system. Little was changed with regard to normal operation within 
Masslynx 4.1, the software that is primarily responsible for the operation of the mass 
spectrometer. The largest change was to how one creates a sample list. 
 A screen capture of the sample list from Masslynx can been seen in Figure 4-11. 
Normally, each row corresponds to a single analysis. Because of the need to store a gradient 
prior to trapping the sample, multiple rows are needed for a single analysis. Methods 
pertaining to each step were created to facilitate ease of use. The first line needed is a 
gradient loading method. At the end of the gradient loading, valves states are reconfigured to 
allow for trapping and the mobile phase conditions are changed to be amenable to this mode 
of operation. The second line required for operation is for sample injection and trapping. 
There are a significant number of timing events associated with this method. Initial settings 
entered into the events tab must be set to allow trapping operation. This should be a 
continuation of the valve states used at the end of the gradient loading method with mobile 
phase conditions amenable to sample trapping (0.5% acetonitrile). Trapping continues for an 
amount of time defined by the user and typically a volume three times the sample loop 
volume is used. Once this is complete, valve states are changed to allow for high pressure 
operation. When this occurs, an additional signal is sent to the mass spectrometer to begin 
data collection and the -903 pump is activated by applying pressure via the pneumatic 
solenoid valve. For short analysis times, the end of this method could be configured to turn 
 121
off the -903 pump, depressurize the system, and return the valve states to the “gradient 
loading” configuration to allow for the next run to proceed. Typically, more data analysis 
time is required and therefore “linker” methods are employed. 
 The needs for the “linker” methods results from a limitation of 32-bit operating 
systems as mentioned in Chapter 2. With these high-resolution separations, data collection 
rates were at times exceeding 2GB/hr per function (one for low energy collisions, one for 
high energy). Thus, in less than two hours, each function would reach the maximum 4GB 
limit imposed by the 32-bit system. While the mass spectrometer continues to perform scans 
and the XUPLC system continues to elute analytes, no data is saved. In order to overcome 
this limitation, multiple runs were linked together. There are a few disadvantages to this type 
of operation, one of which will be discussed in more detail in section 4.3.3. The most obvious 
disadvantage is that approximately 15 seconds of data are lost for each additional linked run. 
This is certainly not a large amount of data, but it would be ideal to not lose any data. 
Unfortunately upgrading to a 64-bit operating system is not sufficient as Masslynx was 
written in a 32-bit environment and significant software changes would be required to 
facilitate the use of the 64-bit operating system. 
 While Masslynx is the program that is used to control the mass spectrometer and 
provides access to modify both LC and MS conditions, the nanoAcquity console and 
nanoAcquity inlet method editor are the two programs that are actually running the 
nanoAcquity. Masslynx provides a convenient link to these programs and streamlines the 
user experience by requiring only one application to be physically opened by the user. The 
nanoAcquity console is critically important to the operation of this system. There has been 
much discussion regarding valve state changes with little mention of how this actually occurs. 
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During setup, column flushing, and other non-routine activities, the valve states can be 
directly controlled by accessing the “rear panel” from the troubleshooting pull-down menu 
within the nanoAcquity console. This is highlighted with a red oval in Figure 4-12. In order 
to have enough valve states to properly control all aspects of the system, switches on both the 
sample manager module as well as the nanoAcquity binary solvent manager were needed. 
These can be toggled by clicking on the icon for each of the swtiches changing between a red, 
open switch, and a green, closed switch. Conveniently enough for operation, “red” 
corresponds to a closed Valco on/off valve, while “green” indicates that the pneumatic 
solenoid is energized to allow gas flow to the on/off valve, opening it (Figure 4-13). 
Fortunately, changing these switches can be automated. This is accomplished by accessing 
the inlet method editor. Once in this part of the program, one can edit the timing events 
associated with both the pump and the autosampler by navigating to the “Events” tab and 
inputting the appropriate values (Figure 4-14). In order to assist in the creation of methods, a 
spreadsheet was created where inputting the gradient loading time will output all the values 
needed across all the tables for all windows. 
4.2.5 Constant Pressure & Elevated Temperature 
Constant flow is the standard for HPLC and UHPLC instrumentation. For flow rates 
in excess of 5 μL/min, instrumentation from Waters Corporation operates under open-loop 
control, relying on the stepper motors powering the pistons to deliver the desired flow. For 
flow rates in the nanoliter/min range, sensors measuring the flow rate were added to the 
Acquity UPLC to create the nanoAcquity UPLC. The pressure limitation of the Acquity is 
15,000 psi, however the nanoAcquity is restricted to operation below 10,000 psi as a result of 
the flow sensors. Developing a sensor that operates at 30- or 40,000 psi, as desired for this 
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work, and can regulate flow down to a few nanoliters per minute is a significant engineering 
challenge. Ultimately, repeatability is the desired outcome. Using the -903 pump provided a 
simple solution, although this solution comes with the requirement that constant pressure 
operation is acceptable. There are a few drawbacks to constant pressure systems. If there is a 
leak, there will be no corresponding pressure readout indicating a loss of pressure. If there is 
a clog, there will be no system warning that the pump has gone overpressure. Lastly, the flow 
rate will change during the course of gradient operation. The change in flow rate is the result 
of a change in the viscosity of the mobile phase due to the water/acetonitrile gradient. Prior 
to assembly of the system, the change in viscosity over the course of the gradient was 
modeled at four temperatures – 25, 45, 65, and 85°C – from 0% to 100% acetonitrile, as 
observed in Figure 4-15. At first glance, there appears to be a significant change in viscosity 
among the temperatures and this is true when comparing the different temperatures. However, 
what is more important to consider is the change in viscosity over the course of the gradient, 
which is narrower than plotted, typically in the range of 1-40% acetonitrile. Normalized data 
for the four temperatures was plotted (Figure 4-16) for a more appropriate gradient range. At 
25°C, there is a relative difference of less than 15% through the course of the gradient. By 
increasing the operational temperature to 65°C, this relative difference is reduced to 
approximately 5%. While the relative viscosity change over the gradient was reduced at 
elevated temperature, the viscosity overall was reduced. The consequence was that for a 
given pressure, the flow rate would be greater and therefore an analysis that might require 4 
hours at room temperature, would require 2 hours at elevated temperature, resulting in 
shorter analysis times with equivalent performance in terms of peak capacity. 
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4.2.6 Columns & Running conditions 
 Three capillary columns were used in the evaluation of the XUPLC system. The first 
was 200 cm x 75-micron ID packed with 1.9 μmμ diameter Acquity BEH-C18 particles. The 
second column used to evaluate the system was 117 cm x 75-micron ID packed with 1.5 
micron diameter BEH-C18 particles. The final column used for analysis was a 25 cm x 75-
micron ID column packed with 1-micron BEH-C18 particles. For trapping operation, a trap 
column was packed with 5-micron Symmetry-C18 particles. Traps were 150 micron in ID x 
6.5 cm in length. All particles were supplied by Waters Corporation and the columns were 
custom-packed in house. 
4.3 Results & discussion 
 As with any new system, there were a number of unforeseen problems encountered. 
Proper formation of the gradient and determining valve timings was a significant challenge. 
This was made difficult by the length of the columns used during setup and countless leaks at 
the many ultra-high pressure capillary connections. However, much was learned regarding 
system setup and operation as a result of these issues. Likely the single most challenging 
problem ahead is in the capillary fittings themselves. While the prototype fittings available 
for this work do provide a solution to facilitate the advances in instrumentation shown here, 
they are undeniably challenging to work with and require a skilled user. This is an area where 
additional engineering resources should be invested in order to facilitate the adoption of 
XUPLC. Despite, these difficulties, preliminary chromatograms from the three columns 
tested are promising. This data, along with discussions regarding system setup, operation, 
and troubleshooting will be discussed in the remainder of this section. 
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4.3.1 Gradient Clipping 
As a result of using a gradient storage loop, there is a significant delay volume 
between the pump outlet and the entrance to the storage loop itself. As a result, when the end 
of the gradient is formed by the pump, an additional amount of flow equivalent to the volume 
of connecting tubing is necessary to properly place the gradient. If too much time elapses and 
a greater amount of volume is delivered than required, peak elution will be delayed and the 
analysis unnecessarily prolonged. If not enough volume is delivered, then the initial portion 
of the gradient is clipped. This gradient clipping is demonstrated in Figure 4-17. It can be 
seen at around 18 minutes, there is an abrupt rise in the baseline and elution begins. This is a 
result of the gradient being clipped and a substantial number of peptides are being eluted 
simultaneously. Since the gradient is loaded in reverse, the last portion to be loaded is the 
low organic part of the gradient. When setting up methods, a systematic approach is needed 
to avoid this problem. The most straightforward is to run several consecutive runs using a 
standard and to introduce longer and longer delay times for gradient placement. When the 
TIC chromatogram (not shown) begins to show a gradual rise and fall over the course of the 
analysis, the correct gradient placement delay has been found. 
4.3.2 Leaks 
 By far, the most challenging problem with the XUPLC modification is leaks. Large 
leaks are often easy to identify, as a pool will rapidly form around the suspect connection. 
Small leaks, on the other hand, tend to evaporate before pooling as the system is operated at 
elevated temperature. Frequently, these problems will be diagnosed through observation of 
the chromatogram. Figure 4-18 shows an example of what was supposed to be a gradient 
requiring in excess of 4 hours to complete. It would appear as though a leak developed not 
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long after 60 minutes as peak shapes suddenly become much more closely spaced together 
and elution is completed by 90 minutes. Identifying which connection is leaking becomes the 
challenge. If a leak occurs after the trap column, then there will likely be few or no peaks 
observed, as the majority of the sample will not reach the analytical column. This was not the 
source of the leak for Figure 4-18. For this particular chromatogram, the leak was prior to the 
trap column. The result is that the sample is eluted from the analytical column, but in a 
compressed elution window, as the majority of the gradient volume is lost through the leak. 
These problems can largely be avoided by systematic and careful installation of the capillary 
fittings. When setting up the system, it has also been useful to pressurize it beyond the 
desired operating pressure. Thus, for 30,000 psi operation, the system should be tested at 33 
or 34,000 psi. If a fitting holds for 15 minutes at the elevated pressure, then it will likely not 
be problematic at the operating pressure. 
4.3.3 Data Analysis of linked files 
 The data analysis of the files generated is a seemingly mundane detail, but warrants 
discussion as there are issues that users must be aware of. The ProteinLynx peptide scoring 
algorithm assigns peptides scores and then these scores are used to determine the confidence 
in a protein identification. One of the criteria used is expected retention time. Ordinarily, this 
causes no issues as chromatograms are collected in one file and contain all the peptides from 
the beginning through the end of the gradient. The long gradient times with the longer 
columns employed with XUPLC create the aforementioned file size problems, which must be 
circumvented by essentially tricking the mass spectrometer control software. What happens 
when this occurs is that peptides eluting at the beginning of subsequent linked runs will have 
an unexpected retention time. If the files are individually processed, this turns out to be okay, 
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as the order of the peptides still makes sense. If the files are merged, an option within 
ProteinLynx, then a number of issues present themselves. Peaks are now out of an expected 
order. When the mass spectral data is merged, peaks can also become overlapped that should 
not be. The short-term workaround, until a more permanent fix within ProteinLynx is found, 
is to process the files individually. At times a protein will be identified in more than one 
fraction, but with manual manipulation of the data, these duplicates could be removed. 
Importing the data into Scaffold at this point would also likely simplify the problem as the 
data could be grouped together as its own “sample category”. 
4.3.4 Chromatographic performance of XUPLC 
 The column initially used to test the XUPLC modification was the 200 cm column 
packed with 1.9-micron BEH-C18 particles. An example chromatogram is shown in Figure 
4-19. For this analysis, a 35 μL gradient was employed for the separation. The dead time of 
the column was observed to be 55 minutes and peaks eluted until 210 minutes. This was a 
very aggressive gradient with a roughly 7.2% change in acetonitrile composition per column 
volume. Typically, it is recommended by Waters to employ a gradient change of 1% per 
column volume. Nevertheless, even with this steep approach, full-width, half-maximum 
(FWHM) peak widths were found to be 0.25 minutes resulting in an experimental peak 
capacity of 660 for this separation. The sample analyzed during this run was the total bottom-
up dextrose yeast sample previously analyzed in Chapter 2. In the four hours required for this 
analysis, 153 proteins were identified. Unfortunately, a flattening of the gradient, with a run 
time extending beyond 600 minutes, did not appreciably increase the peak capacity of the 
system and, strangely, resulted in fewer protein identifications. Given that the change in 
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acetonitrile per column volume was much closer to the desired 1% mark, this was both 
surprising and troubling. A similar phenomenon was noticed with the 117-cm column as well. 
 Figure 4-20 shows the results of the use of 1.5-micron particles in a 117-cm column. 
A 45-uL gradient was employed, resulting in a roughly 3.4% gradient change across the 
column – still three times the recommended gradient slope. The resulting average FWHM 
peak widths were nearly the same with a width of 0.26 minutes, an increase of half a second. 
With an elution window of 145 minutes, this resulted in a peak capacity of approximately 
570 and from this analysis, 128 protein identifications were made. The third column used to 
analyze the system performance was much shorter at 25 cm, but with the smallest particle 
diameter of the three at 1 micron in diameter. Using this shorter column resulted in lower 
peak capacities, but analysis times comparable with what is more typically of normal 
nanoAcquity operation. Three different gradients with volumes of 15-, 25-, and 35 μL were 
used resulting in a gradient change across the column of 2.0%, 01.2%, and 0.9%, respectively 
(Figures 4-21 – 4-23). The peak capacity of the short gradient was determined to be 160, on 
par with what was seen from the shortest nanoAcquity method utilized, albeit in two thirds of 
the time. Increasing the gradient length to 25 μL resulted in an analysis time of 90 minutes 
and a peak capacity of 250, a 56% increase over standard nanoAcquity operation. Further 
flattening of the gradient below the recommended level resulted in broader peaks, with an 
average peak width of 0.37 minutes. For the 15- and 25 μL gradients peak widths were 0.26 
minutes, on average. Interestingly, there was a decrease in the number of proteins identified, 
despite the increase in peak capacity. This would seem to indicate that the mass spectrometer 
was having difficulty characterizing the peptides with peak widths less than 15 seconds wide. 
This is not surprising considering the relative standard deviation for peak widths ranged 
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between 20 and 25% meaning that some peaks were quite narrow. Narrow peaks, while the 
goal of the XUPLC separations would have been difficult for the Apex3D algorithm to 
properly characterize given the frequency of the scans and the need for a minimum of 10 
points per peak for proper characterization. 
 When compared to standard nanoAcquity operation with a QTOF Premier, the 
XUPLC system outperformed the nanoAcquity in terms of total unique protein 
identifications and peak capacity. This data is summarized in Table 4-1. Also included in this 
table is analysis time, peak capacity per hour, and proteins identified per hour. In addition to 
the data from the XUPLC operation and standard nanoAcquity operation, results from the 
SynaptG2 discussed in Chapter 2 are also included for comparison. Excluding the SynaptG2 
results, the most proteins were identified by the method using the 200-cm long column 
packed with 1.9 μm particles, with proteins being identified at a rate of 0.64/minute. While 
the 117-cm long column with 1.5 μm particles had four more identifications than the shorter 
column with 1 μm particles, the “productivity” was much better for the shorter column with 
0.99 identifications/minute as opposed to 0.68 identifications/minute for the longer column. 
It is unclear why the shorter column produced a 46% increase in proteins identified/minute 
over the 117-cm long column. Peak widths for the shorter column were wider at 0.37 minutes 
as a result of the shallow gradient in comparison to 0.26 minutes for the 117 cm column. This 
would lead one to believe that the mass spectrometer was having difficulty handling the 
narrow peaks eluting from the longer column. A steeper gradient on the short column had 
productivity values that remained high, 0.94 identifications/minute and peak widths of 0.26 
minutes. There is likely a balance to be maintained between overall peak capacity and peak 
widths. Clearly this is an area that needs to be investigated further to determine the 
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appropriate conditions for proteomic analyses with higher pressure operation. Lastly, as in 
Chapter 2, the data from the SynaptG2 was the best in terms of proteins identified per hour at 
4.0. If one were to look at the difference between the QTOF Premier and the SynaptG2, there 
was a 6-fold increase in protein identifications. Extrapolating, one could expect upwards of 
900 protein identifications using the 200-cm long column where 153 proteins were identified 
with the QTOF Premier. 
 The examples shown thus far employ gradients that are quite steep in comparison to 
what is typically used. Using a longer gradient on the 117 cm long column, fewer proteins 
were identified despite twice the analysis time. The resulting gradient used in the longer 
analysis had a 1.8% change in acetonitrile concentration across the column as opposed to 
3.4% for the faster gradient. Qualitatively, the chromatogram looks good at first glace. 
However, when looking closely at a smaller portion of the elution window, as in Figure 4-24, 
one can immediately notice asymmetric peaks. The peak at 178 minutes is a good example. 
This peak would appear to be overloaded. Looking at more of the peaks in this window, they 
all look overloaded. However, the intensity of these peptides are lower than many of the 
peaks used in the standard tryptic enolase digest used for system performance monitoring. 
Lowering the injection volume did not help this problem and, in hindsight, given the fact that 
all of the peaks exhibit this tailing, it should not have helped. The problem likely lies 
ultimately in the system construction. For typical trapping operation on a nanoAcquity under 
normal operating parameters, a trap column is only 2 cm long. Due to the high pressure 
fittings required to “float” the trap column in excess of 30,000 psi, the minimum length 
possible was roughly 6.5 cm (Figure 4-25). It is suspected that the extra length required by 
the high pressure fittings is causing a misshaped peak shape to elute from the trap column. 
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With a steep gradient, there is enough gradient focusing to mask this problem. However, 
under more shallow gradients, there the analytes do not properly focus on the head of the 
analytical column and the poor peak shape is maintained throughout the analytical column. If 
this is the case, then peak shapes could be substantially improved and therefore peak 
capacities would increase substantially as well. There is some indication of how sharp a peak 
could be by looking at the front of the peaks. If the peak shape more closely approximated a 
Gaussian, one could expect peak capacities to potentially double given the extent of the 
tailing observed. An additional possibility is the release from the trap column in relation to 
the retention of the analytical column. Sorbent choices will significantly impact the 
performance of a trapping setup. As gradients become shallower, the need for less retentive 
trap columns relative to the analytical column becomes increasingly important. Trapping 
operation allows for a greater sample load to be placed on the column, as the ID of the trap 
column is frequently larger than the ID of the analytical column. With only a small portion of 
the sample re-concentrating at the head of the column, it is easier to avoid situations of mass 
overload. However, the re-concentrating or re-focusing effect is critical to the success of 
trapping operation. Once the sample releases from the trap column, the peak shape will be 
poorer than that of what is achievable via the analytical column. To prevent the peak shape of 
analytes eluting from the analytical column being dictated by the performance characteristic 
of the trap column, the sample must momentarily trap and re-concentrate at the head of the 
analytical column before the gradient increase in strength sufficiently enough to cause elution 
from the analytical column. 
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4.4 Future directions 
 While the system has performed well, the peak shape problem likely caused by the 
trap column is an area that warrants further attention. There are a few ways to potentially 
solve this problem. The most obvious, given the difference in trap column lengths between 
the nanoAcquity and XUPLC operation, is to shorten this column. Unfortunately, doing so 
would require a substantial redesign of fused-silica capillary fittings to create such a solution. 
Practically, this is not possible in the short-term. Another approach would be to change the 
packing material from the 5 μm Symmetry C18 particles to something less retentive. A 5 μm 
BEH-C8 would be a good alternative to test. The last option, which is likely to produce to 
most significant change in results and improve the chromatography the most, is to change the 
flow paths. Figure 4-26 is a schematic for the new design, which came about after discussion 
with Keith Fadgen from Waters Corporation. The former design utilized a forward-trapping, 
forward-flush methodology, where analytes are trapped at the head of the trap column and 
then must be flushed through the rest of the trap column before reaching the analytical 
column. With the redesign, a reversed-trapping, forward-flush approach is possible. This 
places the analytes at the outlet of the trap column during trapping, enabling them to release 
and then re-focus at the head of the analytical column without traveling through the trap 
column. A “cleaner” release is expected, which should result in improved peak shapes and 
reduced tailing. Operational modes are shown in Figures 4-27, 4-28, and 4-29. 
 Currently the system has been operated at 30,000 psi. With the flow path 
configuration used for the collection of the data shown in this chapter, the maximum 
operating pressure was 40,000 psi due to the gradient storage isolation valve that was 
required to operate in the open position. The proposed changes to the flow paths would 
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remove this valve and, given previous experience with this type of valve, one could safely 
operate the system in excess of 50,000 psi. The likely point of failure would most definitely 
be the capillary fittings when operating at 50,000 psi. They already are the source of many of 
the problems experienced during setup at 30,000 psi. Continued work is needed to develop 
better fittings that are more user-friendly and capable of handling the added pressure. 
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4.6 Tables 
 
Column Analysis Time 
(min) 
Acetonitrile 
Change 
Peak Capacity Peak Capacity / Min Ave Peak Width, 
FWHM (min) 
Proteins ID'd Proteins ID'd / Min 
200 cm, 1.9 μm 240 7.2% 660 2.75 0.25 153 0.64 
117 cm, 1.5 μm 180 3.4% 570 3.17 0.26 128 0.71 
25 cm, 1 μm 60 2.0% 160 2.67 0.26 58 0.97 
 90 1.2% 250 2.78 0.26 85 0.94 
 120 0.9% 250 2.08 0.37 119 0.99 
        
nanoAcquity 
QTOF Premier 
120 1.1% 180 1.50 0.51 80 0.67 
nanoAcquity 
SynaptG2 
120 1.1% 180 1.50 0.51 485 4.04 
 
Table 4-1. Three columns were evaluated on the XUPLC system. These include a 200-cm column packed with 1.9 μm particles, a 
117-cm column packed with 1.5 μm particles, and a 25-cm column packed with 1 μm particles. The inner diameter for each column 
was 75 μm. The pressure supplied by the Haskel -903 pump was approximately 30,000 psi and the temperature was held at 65°C. 
Gradients of water and acetonitrile were used to elute the peptides and started between 1% & 3% acetonitrile with a final acetonitrile 
concentration of 40% at the end of the gradient. Peak capacities were calculated by dividing the elution window, which was defined as 
the period of time between the first eluting peak and last eluting peak, by the FWHM peak width. The analysis time corresponds to the 
amount of time required from injection-to-injection. Detection was by a Waters QTOF Premier mass spectromter. Proteins were 
identified with PLGS 2.5. The last two lines of the table show data from a standard nanoAcquity setup utilizing a 90-minute gradient 
previously determined as the preferred gradient length with one data set collected with a QTOF Premier and the other with a Waters 
Synapt G2 and are included for comparison with the XUPLC separations. 
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Figure 4-3. A Waters nanoAcquity UPLC with detection by a Waters QTOF-Premier mass 
spectrometer. The pressure limit of the nanoAcquity is 10,000 psi. 
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Figure 4-4. The nanoAcquity UPLC with the XUPLC modification installed. Pneumatic 
components are primarily locatd on the left side of the nanoAcquity stack with the exception 
of the Valco on/off valves. The column heater is mounted to position the outlet of the 
capillary column near the mass spectrometer source. A gradient storage loop is wound 
around a spool and mounted below the temperature control module on the lower right of the 
nanoAcquity. 
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Figure 4-6. A photograph of the pneumatics sub-system showing mounting locations. Note 
the ball valves for manual shut-off and release of gas pressure to the -903. These are installed 
as a safety mechanism in case rapid decompression is required without the use of the 
computer controls.  
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Figure 4-7. Fluidic schematic overview for the XUPLC system. The blue circles represent 
Valco on/off valves. Grey circles represent tees from Valco. The trap column, analytical 
column, and associated tees are housed inside the Waters TCMII for elevated temperature 
operation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 F
g
b
 
 
145 
igure 4-8. Duri
radient storage
etween the stor
ng gradient loa
 loop. The resis
age loop and th
ding, the nanoA
tance to flow fr
e column. 
cquity vent val
om the analytic
144
ve and trap valv
al column is suf
e are closed. Fl
ficient enough 
ow from the na
to prevent the g
 
noAcquity fills
radient from be
 the 
ing split 
 F
c
v
o
146 
igure 4-9. Duri
olumn and then
olume of three
peration, the gr
ng sample load
 to waste. Anal
 times the samp
adient storage l
ing and trapping
ytes are trapped
le loop volume 
oop is isolated 
 the valves are
 on the column
is used to ensur
to prevent any c
145
 configured to a
. Trapping cond
e all of the sam
hanges to the g
llow flow from
itions are typic
ple has been flu
radient. 
 the nanoAcqui
ally 0.5% aceto
shed onto the c
 
ty through the t
nitrile and a mi
olumn. During 
rap 
nimum 
this 
  
F
o
t
p
147 
igure 4-10. Du
pened. This for
he analytical co
revent damage
ring running op
ces flow driven
lumn where an
 to the nanoAcq
eration the vent
 by the -903 pu
alytes are briefl
uity should the 
, nanoAcquity a
mp through the
y re-focused pri
nanoAcquity v
146
nd trap valves 
 storage loop, p
or to elution. T
alve fail. 
are closed and t
ast the trap colu
he nanoAcquity
he gradient stor
mn where anal
 vent valve is o
 
age isolation va
ytes are eluted, 
pen during ope
lve is 
and onto 
ration to 
 F
a
a
i
i
 
 
148 
igure 4-11. Typ
nd frequently m
llows for the sa
nitial condition
ntermediate pos
ically, one line
ore are require
mple injection 
s for the next ru
ition in order to
 of the sample l
d for a given sa
and starts the m
n, although two
 maintain valve
ist corresponds
mple injection. 
ass spectromete
 can be used fo
 states for runn
147
 to an LC/MS a
The first row is
r. Often a third
r shorter analys
ing operation.
nalysis. For XU
 responsible for
 row is used to 
es. If more line
PLC operation
 loading the gra
stop the analysi
s are needed, th
, a minimum of
dient. The seco
s and return the
ey can be added
 two lines 
nd line 
 system to 
 in an 
 F
v
p
149 
igure 4-12. On
alves responsib
anel…” menu 
 the rear of the 
le for manipula
under “Trouble
nanoAcquity ar
ting the flow pa
shoot” for both 
e several switch
th. In order to a
the pump and a
148
es required for 
ccess these dur
utosampler. 
XUPLC operat
ing manual ope
ion. These cont
ration, one mus
rol the Valco on
t navigate to th
 
/off 
e “Rear 
  
F
m
 
 
 
 
 
 
 
 
 
 
 
 
 
 
150 
igure 4-13. Wi
anager rear pa
thin the rear pan
nel and switche
el are many sw
s 1, 2, 3, and 4 
itches. The one
on the sample m
149
s needed for op
anager rear pan
eration are swit
el. 
ches 1, 2, and 3 on the binary s
 
olvent 
  
F
o
T
 
151 
igure 4-14. For
peration. For b
o aid in metho
 automated ope
oth the pump an
d development,
ration, timing e
d autosampler,
 a spreadsheet w
vents are includ
 there is an even
as developed t
150
ed in inlet file, 
ts tab where sw
o allow the user
which is the me
itches and thei
 to more easily 
thod file used b
r associated on/
program the me
y the nanoAcq
off states can b
thods. 
 
uity during 
e defined. 
 151
 
Figure 4-15. Curves showing the change in viscosity as a function of the acetonitrile 
percentage and the temperature are shown here at 25, 45, 65, and 85°C spanning 0% to 100% 
acetonitrile. Most gradients range from 1-40% acetonitrile.13,14 
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Figure 4-16. Data shown in Figure 4-15 was normalized in order to demonstrate the % 
change in viscosity. The figure was also modified to show the difference in viscosity across a 
more typical LC gradient, spanning 0-50% acetonitrile. 
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Figure 4-17. Method development for the XUPLC system is more difficult than for standard nanoAcquity UPLC operation. Clipping 
of the front-end of the gradient can occur if an incorrect delay time is used. The delay is necessary to account for the system volume 
between the pump and the gradient storage loop. This can be observed in the chromatogram shown as at 18.5 minutes there is a 
sudden change from baseline conditions to full-intensity peptide elution. A more appropriate delay volume would result in a gradual 
rise from the baseline as peptides begin to elute. 
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Figure 4-18. As a result of the elevated pressures (30,000 psi), leaks can develop. These are routinely found on the fused-silica 
capillary fittings. The volume of gradient loaded should have resulted in a nearly 300-minute long analysis time. From this 
chromatogram, it would appear as though a leak developed at approximately 63 minutes. A leak is suspected as the gradient is 
unexpectedly progressing much more rapidly with a significant number of peaks being detected in a compressed timescale. The 
location of the leak is likely one of the three connections on the tee prior to the trapping column as there are still peptides being 
detected. A leak at the second tee results in a significant loss of sample and no peaks are seen as a result. 
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Figure 4-19. A 200-cm x 75 μm ID capillary column packed with 1.9 μm BEH C18 particles was operated at 30,000 psi and 65°C. 
The gradient was 35 μL of 4-40% acetonitrile. A peak capacity from the full-width, half-maximum data outputted from ProteinLynx 
yields a peak capacity of 660 for this separation. A total of 153 proteins were identified from this separation. 
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Figure 4-20. A 117-cm x 75 μm ID capillary column packed with 1.5 μm BEH C18 particles was operated at 30,000 psi and 65°C. 
The gradient was 45 μL of 3-40% acetonitrile. A peak capacity from the full-width, half-maximum data outputted from ProteinLynx 
yields a peak capacity of 570 for this separation. A total of 128 proteins were identified in this separation. 
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Figure 4-21. The elevated pressure permits the use of longer columns with modestly sized particles (1.5 and 1.9 μm). Also possible is 
the use of 1 μm particles. A 25 cm x 75 μm ID capillary column was packed with 1 μm BEH C18 particles and operated at 65°C. The 
gradient had a volume of 35 μL spanning 1-40% acetonitrile. Run times more consistent with what is typically of the nanoAcquity 
UPLC are possible with this shorter column. In this analysis, 119 proteins were identified in a total analysis time of 120 minutes with 
a peak capacity of 250. For standard nanoAcquity operation, a 90-minute gradient resulting in a total run time of 120 minutes resulted 
in 80 protein identifications and a peak capacity of 190. 
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Figure 4-22. A 25 cm x 75 μm ID capillary column was packed with 1 μm BEH C18 particles and operated at 65°C. The gradient had 
a volume of 25 μL spanning 1-40% acetonitrile. Run times more consistent with what is typically of the nanoAcquity UPLC are 
possible with this shorter column. In this analysis, 85 proteins were identified in a total analysis time of 120 minutes with a peak 
capacity of 250. The same peak capacity was the result of narrower peaks with this length of gradient as compared to the gradient used 
in for the chromatogram in Figure 4-21. The reduction in identified peaks can likely be attributed to the narrow peaks not being 
characterized as well by the Apex3D algorithm within ProteinLynx. 
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Figure 4-23. A 25 cm x 75 μm ID capillary column was packed with 1 μm BEH C18 particles and operated at 65°C. The gradient had 
a volume of 15 μL spanning 1-40% acetonitrile. In this analysis, 59 proteins were identified in a total analysis time of 120 minutes 
with a peak capacity of 160. This method requires 60 minutes from injection-to-injection and has a comparable peak capacity to the 
nanoAcquity in 2/3 the analysis time. 
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Figure 4-24. The same 117-cm column with 1.5 μm particles as used in the analysis shown in Figure 4-20 was used here with a 
gradient approximately twice the length. There was only a slight improvement in peak capacity and fewer proteins were identified. 
Close examination of the peak shape reveals substantial tailing. Mass overload is not suspected as this is exhibited by low intensity 
peaks as well. Reducing the mass of sample injected did not result in peak shape improvements either. The forward-trapping, forward-
flush operation is suspected to be contributing to this problem. The trap column is much longer (6.5 cm) than what is typically used in 
this type of operation on the nanoAcquity (2 cm). This additional length may be broadening the peaks sufficiently such that they 
cannot properly focus at the head of the analytical column. 
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Figure 4-25. Inside the column heater module are the trap column, analytical, and hardware required for operation. The two tees and 
either end of the trap column are mounted to a slotted piece of ¼” aluminum plate to facilitate assembly. The tees can be mounted 
with a screw from the back. The analytical column is coiled and taped to the surface of the heater to ensure that it is at the proper 
temperature. A Teflon junction is used to connect the outlet of the column, which remains inside the heater, to a piece of capillary 
serving as a transfer line between the column and the spray tip. 
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CHAPTER 5: APPLICATION OF PRE-FRACTIONATION METHODOLOGY FOR 
A DIFFERENTIAL ANALYSIS OF A MOUSE EMBRYONIC FIBROBLAST BETA-
ARRESTIN 1,2 DOUBLE-KNOCKOUT 
 
5.1 Introduction 
5.1.1 Beta-arrestin background 
G-protein coupled receptors (GPCRs), which are seven-transmembrane domain 
proteins, comprise the largest and most diverse class of cell surface receptors.1 It has been 
estimated that nearly half of all drugs available for clinical use target these proteins whether 
to block a signaling pathway altogether or to stimulate a pathway by mimicking a GPCR 
ligand. Pathways GPCRs are involved in include those responsible for neurotransmission, 
physiologic homeostasis and metabolism as well as controlling cell growth, proliferation, 
differentiation, and apoptosis across many cell types.2 Given their prominent role in the 
regulation of cellular processes, proteins that are associated with these receptors are of 
interest to researchers for other possible avenues of therapeutic advancement. Over the past 
decade, arrestin proteins, specifically β-arrestin proteins (arrestins 2 and 3), have been shown 
to have a role in cell signaling beyond their classically known function as GPCR 
desensitizing proteins.2-4 Under the classical understanding of β-arrestin function, once a 
GPCR is bound it can no longer activate G-proteins and ceases the cell signaling cascade. 
The new information that has been reported shows that while β-arrestins effectively 
desensitize the GPCRs, they also participate in a signaling pathway on their own right.2,5,6 
 167
G-protein signaling is initiated by the binding of a ligand, such as catecholamine, by a 
GPCR after a systemic release of the ligand. A heart attack would be one example of such an 
event. Upon binding of the ligand, the receptor acts to induce a conformation change in the 
heterotrimeric G-protein complex thereby promoting the exchange of GDP for GTP (Figure 
5-1).7,8 Once this occurs, The G-protein complex dissociates into Gα and Gβγ subunits. Each 
subunit is then capable of activating a different second messenger pathway as part of the 
signaling process. The GPCR, once the G-protein complex has dissociated, is free to induce 
changes and initiate signaling cascades in additional G-protein complexes as the ligand 
remains bound until phosphorylation by GRK (G-protein coupled receptor kinase). By 
phosphorylating the receptor, a change in GPCR conformation is induced promoting the 
binding of β-arrestins upon which the GPCR can no longer signal additional G-proteins and 
marks the beginning of signal pathway down-regulation. In the classical understanding of β-
arrestin function, after the binding of the β-arrestin, additional proteins are recruited forming 
a clathrin-coated pit as part of endocytosis. After the endosome is formed, the receptor can 
either be degraded or recycled. 
The role of the β-arrestin, however, is not confined to receptor desensitization as 
previously thought, but has additional roles in initiating additional second messenger 
pathways. One such pathway involves the transactivation of the epidermal growth factor 
receptor (EGFR) (Figure 5-2). This transactivation process is initiated after the β-arrestin 
promotes an Src kinase to phosphorylate matrix-metalloproteinase (MMP). MMP, in turn, 
causes the splitting of the Heparin-Binding epidermal growth factor (HB-EGF) outside the 
cell, which directly causes the EGFR transactivation by acting as a ligand.8 Additional 
signaling occurs within the cell, but ultimately this pathway is determined to have beneficial 
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effects not seen by the classically known G-protein pathway. In fact, through a mouse model, 
it has been demonstrated that chronic stimulation of the G-protein mediated pathway has 
many adverse cardiac effects.4,9,10 These include a decrease in the strength of contraction 
resulting in the enlargement of the heart as well as thickening of the muscle tissue in the 
heart. Conversely, signaling that occurs as the result of the β-arrestin pathways have been 
found to have many cardioprotective effects including myocyte proliferation and anti-
apoptotic effects.8  
Unlike the signaling onset for G-protein mediated pathways, the onset of the beta-
arrestin dependent pathway is slower and increases gradually. This signaling pathway also is 
sustained for much longer and does not experience the rapid decrease as is associated with 
the G-protein mediated pathway once bound by a beta-arrestin.4 The prolonged signaling 
effect combined with the cardioprotective effects makes for an appealing target for further 
research. The β-arrestin pathway is of interest and could lead to a new class of drugs to treat 
heart disease, the largest killer of both men and women in the United States. This result is a 
long way off, however. Most work to this point has focused on the associations between β-
arrestins and other proteins. Yates and Lefkowitz studied this by applying the MudPIT 
technique to a mouse cell model.11 From this work they were able to find 173 proteins that 
were associated with β-arrestin 1, 266 proteins associated with β-arrestin 2, and 102 proteins 
that were found to be associated with both forms for a total of 337 unique proteins. These 
associations were also broken down in to classes, demonstrating that proteins were found to 
be involved in a wide variety of functions. 
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5.1.2 Previous studies of MEF lysates by online 2DLC 
The differential analysis of the mouse embryonic fibroblast cell lysate with a β-
arrestin 1,2 double-knockout had previously been studied in the Jorgenson lab by Brenna 
Richardson utilizing a combined top-down/bottom-up approach with a multidimensional 
separation of intact proteins followed by a flow split to allow for simultaneous fraction 
collection and intact mass determination via TOF-MS.12 The online multidimensional 
separation utilized anion-exchange chromatography in the first dimension followed by 
reversed-phase in the second dimension. Once the intact data was collected, fold-changes 
were determined and fractions of interest then further analyzed by bottom-up methods to 
hopefully identify proteins of similar mass, allowing for identifications. This technique 
identified a total of 68 differential masses from the intact data with about 50% of these 
masses matching proteins identified through bottom-up measures. 
Ultimately, it was deemed necessary to revisit this differential comparison with 
different methods to try and improve upon the results found by Richardson. A more 
comprehensive analysis relying less on mass correlations was believed to have a better 
chance of not only identifying proteins of interest, but also allowing for more confident 
identifications as sequencing data would be available as a result of the workflow previously 
discussed in Chapter 3. 
5.2 Experimental 
5.2.1 Overview of experimental method 
Much of the analysis of the mouse embryonic fibroblast (MEF) cell lysate samples is 
the same as was done previously in Chapter 3 for the fractionated analysis of yeast. A 
different fractionation scheme was used for the reversed-phase analysis as an attempt to 
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improve the number of protein identifications through more complete fraction collection. The 
most significant difference between the two methods is in the sample preparation. Whereas 
for the yeast, samples could be prepared ahead of time and thawed prior to use, this was 
found to have detrimental consequences for the analysis of the MEF lysates. In order to 
maintain sample solubility without the addition of salts and surfactants incompatible with 
liquid chromatography, the cells were thawed, lysed, and analyzed within the same day. 
While kept on ice, the lysate samples were never frozen. This resulted in an improvement in 
the protein content of the samples and allowed for a greater amount of protein to be used for 
the analysis. A second key difference was in the sample injection itself. With the yeast 
samples, the inclusion of formic acid with the sample injection was not found to be necessary 
to maintain sample solubility beyond the inlet frits of the reversed-phase column. For the 
MEF samples, a dilution with an equal volume of 88% formic acid was necessary to allow 
the proteins to move beyond the inlet frit and concentrate at the head of the column. 
Backpressure was significantly reduced during the reversed-phase separation and subsequent 
blanks were found to be clean as a result of the inclusion of formic acid in the sample 
injection. 
5.2.2 Preparation of MEF protein extracts 
The mouse embryonic fibroblasts cells were provided by Dr. Kevin Xiao from the 
Lefkowitz lab at Duke University School of Medicine. β-arrestin 1,2 double knockout mouse 
embryos were prepared as previously described.13 Mouse embryonic fibroblast cells (MEF) 
were prepared and cultured according to the 3T3 protocol of Todar and Green.14 Cell 
harvesting and lysis was performed by first harvesting the cells in a phosphate buffered saline 
solution, centrifuging, and removing the supernatant to form a cell paste. The solution for re-
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suspension was composed of 25 mM ammonium bicarbonate with the following phosphatase 
inhibitors: 1 mM potassium fluoride, 1 mM sodium pervanadate, 1 μM microcystin, and 10 
nM calyculin A. Protease inhibitors from Roche were added as well at 1 tablet/10 mL. Cells 
were re-suspended in 0.5 mL of the buffer described above and subjected to three 
freeze/thaw cycles. An additional 0.5 mL of buffer was added and samples were dounced for 
20 strokes. Sonication was performed for a total of 50 seconds by sonicating for 10 seconds 
followed by a cooling time of 20 seconds at 30% power (Branson 250 sonifier, Danbury, CT). 
Centrifugation at 15,000 x g for 30 minutes at 4°C was performed in order to remove cell 
debris and insoluble protein. Filtration was performed with a 0.2 μm filter to further clean up 
the sample. A Bradford protein quantitation assay was then performed as done for the yeast 
samples in Chapter 2. The concentration of protein in each sample was found to be 4.0 
mg/mL for the double-knockout sample and 5.5 mg/mL for the wild-type sample with 
relative standard deviations of 4.6 and 7.8%, respectively. 
5.2.3 LC/MS conditions 
For both the anion-exchange and reversed-phase intact protein pre-fractionation 
strategies, 2.5 mg of protein was injected onto the column for each sample type. For the 
reversed-phase separation, it was necessary to dilute the sample to a final volume of 1.24 mL 
with formic acid to maintain solubility past the inlet frit. The anion exchange column used 
for the analysis was a Waters BioSuite Q SAX, 7.5 mm x 7.5 cm with 10 μm particles and 
1000 Å pores and was operated at the manufacturer’s maximum recommended temperature 
of 50°C. Mobile phase A for the anion exchange separation was 25 mm ammonium acetate at 
pH 9.0 with mobile phase B being 1M ammonium acetate, also at pH 9.0. Gradient 
conditions for the anion exchange separation can be found in Table 5-1. The reversed phase 
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column was an Agilent PLRP-S, 4.6 mm x 30 cm with 5 μm particles and 300 Å pores and 
was operated at 80°C. Mobile phase A was 90% water, 5% acetonitrile, and 5% isopropanol 
with 0.2% TFA. Mobile phase B was 50% acetonitrile and 50% isopropanol with 0.2% TFA. 
Gradient conditions for the reversed-phase separation can be found in Table 5-2. The peptide 
separation was by RP-UPLC-MSE and was previously described in section 3.2. Mass 
spectrometric data processing was also previously described and again utilized PLGS 2.5 for 
peptide assignments and Scaffold 3.3 for database searching and statistical analysis. 
5.3 Results & Discussion 
5.3.1 Comparison of AXC40 to RP18 
 The anion exchange fractionation was completed using the same liquid 
chromatographic conditions as was done for the anion exchange separation of Baker’s yeast 
in Chapter 3. As was seen with the yeast sample, there was a significant elution of proteins in 
the dead volume followed by a lull in the elution (Figure 5-3). Peaks of similar width were 
observed and the separation was otherwise unremarkable with differences being observed 
between the two sample types. The reversed-phase fractionation scheme was modified to 
collect fractions over more of the gradient in response to the elution pattern observed from 
the analysis of yeast, where a significant number of proteins were tailing into later fractions 
as discussed in Chapter 3. This was accomplished in two ways. More fractions were collected 
over a longer period of time. In all, 54, 1-minute wide fractions were collected. These were 
combined to form 18, 3-minute wide fractions, which then underwent further analysis by 
LC/MS. Fractions were pooled in this manner out of consideration for computational 
resources and overall analysis time. Increasing the number of fractions creates increasingly 
large data sets, which tax the software and systems used to analyze the data. Further 
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improvements to software would facilitate finer fractionation and allow for more 
comprehensive analyses. The time aspect also is a concern, as running 18 fractions in 
triplicate for two intact protein samples requires upwards of 200 hours. The gradient was also 
steepened to reach a higher percent of the 50/50 acetonitrile/isopropanol mobile phase more 
quickly to ensure all proteins had eluted. By increasing the gradient steepness, the elution 
window was compressed (Figure 5-4) with respect to what had previously been seen for the 
yeast samples. 
It was assumed that the number of unique proteins would decrease slightly as a result 
of this additional grouping and steeper gradient. However, it was believed that overall there 
would be a greater number of protein identifications made as a result of the reversed-phase 
pre-fractionation than what was found by anion-exchange methods. This expectation was 
based on the results shown in Chapter 3 where with even fractionation of the gradients, 
reversed-phase outperformed anion-exchange by a 2:1 margin. When fractionation was 
doubled for the anion-exchange pre-fractionation, there was still a significant advantage in 
choosing reversed-phase for the pre-fractionation. In practice, these assumptions proved to be 
incorrect for the mouse samples. Ultimately, the anion-exchange pre-fractionation with 40 
fractions was able to identify 355 unique proteins from the mouse embryonic fibroblast cells 
whereas only 215 identifications were made from the reversed-phase fractionation (Figure 5-
5) when using the criterion that proteins must be identified in two of three replicate analyses 
with a confidence greater than 95%. Somewhat surprising, however, was the lack of overlap 
between the two methods, with only 82 proteins found in common and could be indicative of 
a more complex sample. The reversed-phase method resulted in the identification of 61% of 
the total number of unique identifications made by the anion-exchange method. Also of 
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interest is the fact that 133 additional proteins unique to the reversed-phase approach, 
representing an increase in protein identifications of 37%, were observed. The discrepancy in 
identified proteins and the small amount of overlap between the data sets can likely be 
attributed to the more complex sample composition of the mouse cell line with the potential 
for many more proteins to be present and likely with a greater variety of post-translational 
modifications. This can present issues with the chromatography of the intact proteins and 
proteins, which are well behaved during the anion-exchange separation, may not 
chromatograph well for reversed-phase method, and vice-versa. An example of a problematic 
class of proteins are those which are not retained, such as positively charged proteins in the 
anion exchange separation. Also troublesome are proteins that elute across a substantial 
number of fractions. More hydrophobic proteins are those likely to precipitate on the inlet 
frits, and this effect was observed in particular when fractionating the MEF samples on the 
reversed-phase column (5-6) Another possible explanation for the lack of overlap may be due 
to different frit materials or mesh sizes used in the frits by the manufacturers. Differences in 
protein adsorption at the inlet frits would not be unexpected between the two columns. 
Therefore, the proteins observed, or not, in one method with regard to another, may not be 
the result of the chromatographic mechanism used to separate the proteins, but an undesirable 
consequence of practical column construction considerations. Inclusion of formic acid to 
solubilize proteins, especially membrane proteins, has been reported and was necessary to 
produce reproducible injections for the mouse embryonic fibroblast cell lysates (Figure 5-
6).15 Without formic acid injections, there was a substantial rise in the back pressure from the 
column and less signal from the UV detector as observed in Figure 5-7. By diluting the 
sample into a 50% formic acid solution, no rise in the backpressure over blank runs was 
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observed and a more substantial UV signal resulted, indicating that more of the proteins in 
the sample were remaining soluble beyond the frits. 
  For the remainder of the results and this discussion, less stringent requirements than 
those used for the differential comparison were used. Where previously a protein must have 
been identified in two of three replicates with a confidence greater than 95%, a protein only 
was required to be found in one of three replicates with a confidence greater than 95% in 
order to be counted. This was done to facilitate a better evaluation of the chromatography 
where a differential comparison was not of primary concern. Previously mentioned was the 
difference in fractionation schemes applied to this mouse embryonic fibroblast cell line than 
what had previously been done with yeast samples. Not surprisingly, this had a profound 
effect on the number of fractions a protein eluted across and ultimately the number of protein 
identifications. The overwhelming majority of proteins, 78%, fractionated by reversed-phase 
chromatography were identified in only one fraction. While this initially appears to be a 
beneficial consequence of the coarse fractionation scheme, the broad fractionation approach 
may have resulted in a peptide sample too complex to be properly analyzed by the second 
dimension workflow. Figure 5-8 and Figure 5-9 show the difference between the reversed-
phase and anion-exchange fractionation schemes with respect to the number of fractions per 
protein identification. The increased and more even fractionation of the anion-exchange 
method does split more peaks with only 31% being found in one fraction. The percent of 
proteins being found in two fractions was determined to be 11% for reversed-phase pre-
fractionation and 22% for anion-exchange pre-fractionation and those found in three or more 
fractions was 11% for reversed-phase pre-fractionation and 47% for anion exchange pre-
fractionation. 
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 To further evaluate the fractionation schemes, proteins counts were plotted as a 
function of the fraction in which they eluted. Thus, in areas of the chromatogram where there 
were few proteins eluting off of the first dimension separation, few proteins were identified. 
For both fractionation schemes, reversed-phase (Figure 5-10) and anion-exchange (Figure 5-
11), there are regions of especially dense protein elution as well as areas in the separation 
where there were few additional proteins identified. The trends generally follow what was 
observed for the analysis of yeast in Chapter 3. For the reversed-phase separation, essentially 
no proteins were identified during the first 6 minutes of fraction collection and relatively few 
new proteins were identified during the last half of the fraction collection. Given the 
somewhat relaxed requirements for identification purposes, 623 unique proteins were 
identified, but not quantified when viewing the data in this way. At times, upwards of 120 
proteins were identified from a 3-minute wide fraction with the bulk of the protein elution 
occurring between fractions three and nine. For the anion exchange separation, after the 
initial elution of proteins in the dead time, the expected lull in elution followed, which then 
transitioned into a period of significant elution. This too tapered off, although it was more 
consistent than the reversed-phase elution of proteins with only the last fourth contributing 
little in the way of new identifications. Using the less stringent requirements for 
identification, 930 unique proteins were identified. When comparing the thresholds for 
identifications versus identifications used for fold-change identification we do see a marginal 
difference between the two sample types. For the reversed-phase pre-fractionation, only 71% 
of the total number of proteins identified once at a confidence level of 95% were also 
identified a second time allowing for use in the differential comparison. This is in 
comparison to the anion-exchange method where 81% of the proteins found once were also 
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found twice or more. This 10% difference could be due to random variation, but it may be 
more indicative of the inefficiency of the reversed-phase pre-fractionation combining too 
many proteins into one fraction. It is possible that with improved fractionation of the 
reversed-phase separation, fewer proteins and therefore fewer peptides would be contained 
within a given fraction. The result is that the mass spectrometer would have a better 
opportunity to fragment these peptides without raising the background noise significantly and 
could present the data analysis programs with cleaner data in order to better sequence the 
peptides. With better data, more proteins could be identified and the gap between the two 
methods could likely be narrowed. Ultimately, the data shown comparing the number of 
fractions per protein and conversely the number of fractions per protein indicate that there is 
a balance to be maintained with fractionation. The most efficient route is likely that which 
abandons fractionation based on even time intervals in favor of a more targeted approach 
using the UV data as a guide. 
5.3.2 Comparison of Pre-fractionation to Online 2DLC results 
 This cell line was previously studied as part of the research undertaken by Brenna 
Richardson in the last chapter of her dissertation. The approach utilized by Richardson 
involved a mixed top-down, bottom-up methodology where the intact mass was determined 
by mass spectrometry and later compared to bottom-up data from fractions collected during 
the top-down analysis. A number of proteins were found to be differentially expressed 
between the wild type and double-knockout samples with fold changes that would be 
considered to be significant (greater than 1.5). 
 Unfortunately, none of these proteins were found to be of interest, as they are not 
believed to be involved in any of the pathways of interest for β-arrestin proteins. There are a 
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number of reasons why this may be the case. A key limitation of this technique is the need to 
be able to detect intact proteins. Few proteins were ever observed beyond 40 kDa, so 
immediately there was a significant reduction in the number of proteins one could expect to 
observe. The other, more significant contributor to the difficult nature of this analysis is in 
regard to the abundance of signaling proteins. Typically proteins involved in signaling 
pathways are not expressed in large quantities making for a more difficult analytical 
challenge to observe these proteins. Additionally, proteins involved in signaling are often 
found to be associated with the cell membrane. Only cytosolic proteins were analyzed by this 
method owing to solubility requirements for the two-dimensional separation of intact 
proteins used in this analysis. Other challenges limiting the number of protein identifications 
are due to the limited number of intact masses that were able to be determined. This is due to 
a competition for ionization. Also, as a result of the difficulty associated with the ionization 
of large proteins, few proteins were identified above 40 kDa. Lastly, an additional challenge, 
which was never overcome despite work to create data filtering programs and comparison 
tools, was the problem of associating a deconvoluted mass from the intact protein separation, 
with the mass reported from the bottom-up analysis. Without knowing which post-
translational modifications were present, if any, results from this type of comparison would 
always be suspect, with few ways to confirm identifications. So, when one takes into account 
all of these factors, it is of little surprise that the differentially expressed proteins identified 
were not found to be of interest to the collaborators at Duke University. 
 It was hoped that a more comprehensive analysis, where peptides were being 
analyzed by mass spectrometry as opposed to intact proteins, would sufficiently lower the 
limits of detection to enable detection and relative quantitation of proteins associated with β-
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arresting signaling pathways. Overall, there was a significant increase in the number of 
differential proteins identified by both reversed-phase and anion-exchange approaches. 32 
differential proteins were identified by the online method utilized by Richardson in her 
analysis of these samples. With the offline pre-fractionation approach, 141 were found by the 
reversed-phase method and 295 by the anion-exchange method, again with a fold-change 
greater than 1.5 as the minimum threshold. When comparing the proteins identified by 
Richardson to the list of differential proteins generated by the anion exchange pre-
fractionation approach, approximately half of the 32 masses identified in the earlier work 
were identified. Unfortunately, these overlapping proteins were not always found to be up-
regulated in the same sample, and actually about half of this subset was found to indicate the 
opposite expression level. Fold changes for both analysis techniques were typically less than 
4. When looking specifically at the spectral counts, as determined through Scaffold, for the 
proteins found in common between the two techniques, the numbers were low. Therefore, it 
is not necessarily unexpected that the results are contradictory given the relatively small fold 
changes at low intensity levels. For the reversed-phase pre-fractionation there was even less 
overlap between the two techniques given the small number of proteins identified overall by 
this fractionation approach. 
5.3.3 Comparison of Pre-fractionation to Literature 
 Likely the best research to date on the beta-arrestin interactome comes from the 
collaboration between Yates and Lefkowitz employing the MudPIT approach as well as gel-
based approaches for a comprehensive analysis. In this work, interacting proteins from 
HEK293 cells overexpressing both beta-arrestin 1 and 2 were immunoprecipitated and 
analyzed by mass spectrometry.11 Many replicates (6-8) were conducted in an effort to 
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increase the reliability of the identifications. From this work a total of 337 unique protein 
identifications were made spanning a wide-range of functions and locations within the cell. 
The majority (53%) were found in the cytoplasm, but there were also significant 
contributions from proteins found in the nucleus, nucleolus, and membrane. Functions 
included signal transduction, nucleic acid binding, cellular organization, metabolic functions, 
and a substantial portion of unknown functions at almost 42% of the total.11 This type of 
analysis was much different from that which was conducted in the research presented in this 
chapter, however. For the research completed by Yates and Lefkowitz, the purpose of the 
study was to induce as many associations between beta-arrestins and other interacting 
proteins. The overexpression of beta-arrestins as well as the immunoprecipitation would be 
expected to help with the limit of detection immensely as their approach was exceptionally 
targeted with respect to the analysis of cell lysates with few modifications. 
 Analysis of the cell model used in the studies presented here with the more subtle 
changes than the samples used in the research of Yates and Lefkowitz unfortunately shared a 
similar outcome with the methods attempted by Richardson in her studies. Despite a 
substantial increase in the number of differential proteins, an increase of approximately 10-
fold, only a few proteins were identified that were also identified as interacting with beta-
arrestins by the Yates study. Interestingly enough, there was one additional match from the 
reversed-phase data than from the anion-exchange data, which was quite a surprise given the 
fewer number of overall identifications. In total, there were four classes of proteins from the 
anion exchange method and five classes of proteins from the reversed phase method that 
matched the reported results. These results are summarized in Tables 5-3 & 5-4 and 
described in the following text. 
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The 14-3-3 (1433_mouse) scaffolding proteins were identified as being down-
regulated in the double-knockout sample and were unique to the anion exchange data set. Six 
isoforms were identified in total with three present only in the wild-type sample and three 
with an average 5-fold change in expression level. Little is known regarding the interactions 
between these two classes of proteins. Both beta-arrestins and the 14-3-3 proteins are known 
to function as scaffolding proteins, but are assumed to serve as scaffolds for different types of 
proteins as the interactomes of beta-arrestin and the 14-3-3 proteins was only determined to 
be 8%. Also found from the anion exchange pre-fractionation was annexin, a protein known 
to participate in signaling as well as two myosin proteins (MYH9 and Q3UH59). The 
annexin proteins were found in the reversed-phase data in addition to both myosin proteins. 
Also found was another signaling protein, catenin-beta (CTNB1). Several proteins involved 
with cellular organization were identified. These included several forms of tubulin (TBB3, 
TBB6, TBB2C, and TBB5), cofilin 1 (COF1), and caldesmon (CALD1). For the reversed-
phase method, the annexin and catenin proteins were only identified in the double-knockout 
sample. The annexin result for the reversed-phase method was the same as observed for the 
anion-exchange method. The remainder of the proteins identified in the reversed-phase 
method were identified as being either only found in the wild-type sample, suggesting down-
regulation in the double-knockout sample, or were clearly determined to be down-regulated 
in the double-knockout sample with an associated value for the fold change in regulation. 
COF1, TBB3, and TBB6 were found to be only in the wild-type sample with TBB2C, 
CALD1, and TBB5 being down-regulated in the double-knockout sample with fold changes 
of 2.3, 2.1, and 1.6, respectively. 
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5.3.4 Comparison of MEF to Yeast 
 The comparison between the cell lysates from mouse embryonic fibroblast cells and 
yeast reveals striking differences. With the yeast analysis in Chapter 3, it was clear that the 
reversed-phase fractionation with only 20 fractions was a significant improvement over the 
anion exchange methods, even when twice the number of fractions were analyzed. For this 
mammalian sample, the increased fractionation appears to be of greater importance as there 
was a significant increase in protein identifications from the anion exchange method with 
greater fractionation than the reversed-phase method. A possible explanation for this is that 
there are simply more proteins to be identified in the mammalian samples creating a more 
complex sample. As increased fractionation would help alleviate sample complexity, the 
increased fractionation of the anion-exchange method utilized in this comparison would be 
expected to be of great utility and allow for the improvements in protein identifications over 
methods with fewer fractions. Clearly, each sample must be treated individually and methods 
must be tailored for each analysis. While it would be convenient to apply methods without 
any modifications to any potential sample, these results indicate the sample complexity of 
mammalian cells in comparison to yeast require more experimental planning on the part of 
the investigator. However, simply increasing the fractionation is not the answer as with 18 
fractions, the analysis time required is already a significant investment that is not likely to be 
practical for routine or even semi-routine analysis. 
To compare specifics of the two samples, when analyzing Baker’s yeast, the AXC40 
method provided 370 identifications in comparison to 546 from the RP20 method, or 68%. 
Of the 370 identifications, though, 70 were unique to the AXC40 method, resulting in an 
additional 13% increase in protein identifications when the results of two methods are 
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combined. When analyzing the MEF samples, the situation was much different. As already 
mentioned, the reversed-phase method found fewer proteins than the anion exchange method, 
with reversed-phase identifying only 61% as many proteins. The lack of overlap was striking 
and the fact the additional contributions from the method identifying fewer overall proteins 
rose from 13% to 37% is surprising. 
5.4 Conclusions 
 The ability to determine proteins that are up or down-regulated as the result of the 
beta-arrestin double-knockout ultimately may prove to be too subtle a challenge for the type 
of analysis being conducted. As with the approach by Yates and Lefkowitz, a more targeted 
methodology will likely be needed to learn anything beyond what has previously been 
reported. The fact that very few proteins involved in cell signaling that were previously 
reported to interact with beta-arrestin proteins were identified by the pre-fractionation 
approaches is somewhat discouraging. Coming back to the idea that signaling proteins are 
often among the least expressed and often associated with the membranes, future work 
should focus on inclusion of membrane proteins in the analysis as well as the use of better 
mass spectrometry through newer instrumentation with lower limits of detection. That said, 
there are a couple alternatives that can be tried in the interim that may allow for more 
identifications in less time via targeted fractionation, the use of the XUPLC system described 
previously, and the incorporation of both of these strategies along with immunoprecipitation 
studies. 
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5.5 Future Studies 
5.5.1 Improved fractionation 
Comparisons of the UV traces to the number of proteins identified per fraction for 
both the yeast and mouse samples revealed that the UV data was a good predictor for where 
unique proteins would be identified. This is somewhat contradictory to what has recently 
been reported in the literature,16  but given our results across both sample types for multiple 
fractionation schemes involving two different intact protein separation strategies, the UV 
data appears to be sufficient for guiding a targeted fractionation scheme. With targeted 
fractionation, one could lump together fractions at the beginning and end of the intact protein 
separation method where little is occurring and few unique protein identifications are 
expected. This allows for a reduction in analysis time that could be used in one of two ways. 
If one desired to maintain a substantial number of fractions, say 20, then by combining 
fractions at the beginning and end would allow for finer fractionation across the portion of 
the UV trace where there were many peaks eluting. This sort of strategy is particularly 
appealing for the MEF samples, as the reversed-phase method clearly did not fractionate this 
sample enough. The same approach could be applied to the anion-exchange pre-fractionation 
and one could likely cut the number of fractions significantly without deleterious effects as 
fine fractionation could be maintained where needed and fractions where little new 
information is being gleaned could be combined. The other option would be to simply reduce 
the number of fractions even below the 18 analyzed for the reversed-phase method without 
further reducing the number of protein identifications. The needs of the investigator 
ultimately would decide how finely to fractionate the intact proteins with the amount of 
analysis time available for a given sample being the ultimate factor in deciding how many 
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fractions to collect and analyze. Regardless of the outcome, since the UV data is collected 
during fraction collection one would be well suited to finely fractionate the intact protein 
separation and later combine fractions in a manner consistent with level of activity observed 
across the chromatogram. 
5.5.2 XUPLC of peptides 
 Improved fractionation is expected to improve productivity, which is defined as the 
number of protein identifications per hour. Chapter 2 looked at analyzing fractions by a 
commercially available multidimensional approach with results that were less than 
satisfactory given the amount of time required for such an analysis. In Chapter 4, the use of 
XUPLC showed significant promise. While fractionation approaches already require a 
significant investment in time, the use of meter-long columns and hours-long analysis times 
begins to lose some appeal. However, the use of shorter columns packed with smaller 
diameter packing materials resulting in run times comparable to what is currently conducted 
on a commercially available nanoAcquity UPLC system is intriguing. As previously reported, 
twice the number of proteins were identified given a 33% increase in analysis time, which is 
certainly a large improvement in productivity. Combining the targeted fractionation scheme 
with XUPLC would likely provide for significant improvements in protein identifications, 
and therefore an improved differential analysis. 
5.5.3 Immunoprecipitation of beta-arrestin interacting proteins 
 The study of the cell lysates has yielded little in the way of useful information 
regarding beta-arrestin interactions despite multiple analysis techniques being applied. A 
more targeted approach, which was undertaken by Yates and Lefkowitz produced far more 
useful information. Given the relative success of this method, it would seem prudent to 
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incorporate some of the techniques used in the preparation of the sample to be analyzed by 
LC/MS before attempting to further improve the LC/MS methodology. Preparing a better 
sample is likely to yield more fruitful results than spending greater and greater amounts of 
time fractionating intact proteins and analyzing the peptides with the myriad of techniques 
discussed here and in previous chapters. However, with a better sample, the peak capacity 
provided by intact protein pre-fractionation in combination with large peak capacity 
separations in reasonable analysis times as the result of using XUPLC with smaller particle 
diameters could certainly be a worthwhile use of time. 
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5.6 Tables 
 
Time  
 
(min) 
25mM 
Ammonium 
Acetate, pH 9.0 
(%A) 
1M 
Ammonium 
Acetate, pH 
9.0 
(%B) 
0 100 0 
60 0 100 
90 0 100 
90.1 100 0 
 
Table 5-1. Gradient program used for the intact protein pre-fractionation of the yeast cell 
lysates by anion-exchange chromatography. The column used was a Waters BioSuite Q 
SAX, 7.5 mm ID x 7.5 cm with 10 μm particles and 1000 Å pores. The flow rate was 0.5 
mL/min and the column was held at a temperature of 50 °C, the maximum per manufacturer 
recommendations. Forty fractions were collected from 2 to 82 minutes. 
 
 
Time  
 
(min) 
90:5:5 
H2O:ACN:IPA + 
0.2% TFA 
(%A) 
50:50 
ACN:IPA 
+ 0.2% TFA 
(%B) 
0 100 0 
2 100 0 
5 75 25 
45 30 70 
45.5 0 100 
50 0 100 
50.5 100 0 
60 100 0 
 
Table 5-2. Gradient program used for the intact protein pre-fractionation of the yeast cell 
lysates by reversed-phase chromatography. An Agilent PLRP-S, 4.6 mm x 25 cm column 
with 5 μm pores particles and 300 Å pores. The flow rate was 1.0 mL/min. A column 
temperature of 80 °C was used – well below the rated maximum of 200 °C. Fractions were 
collected every minute from 2 to 42 minutes for a total of 40 fractions collected. These 
fractions were later pooled to form the 20 fractions analyzed. 
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Anion-Exchange Pre-Fractionation 
Differential Protein Regulation Relative to WT 
Fold 
Change 
1433B Down Regulated WT Only 
1433E Down Regulated 5.6 
1433F Down Regulated WT Only 
1433G Down Regulated 5.1 
1433T Down Regulated WT Only 
1433Z Down Regulated 4.4 
ANXA1 Up Regulated dKO Only 
ANXA6 Up Regulated dKO Only 
ANXA8 Up Regulated dKO Only 
MYH9 Down Regulated 3.0 
Q3UH59 Down Regulated WT Only 
CTNB1 No Difference - 
TBB3 No Difference - 
TBB6 No Difference - 
TBB2C No Difference - 
TBB5 No Difference - 
COF1 No Difference - 
CALD1 No Difference - 
Table 5-3. Proteins found by the anion-exchange pre-fractionation method that are known to 
associate with beta-arrestin proteins are shown here. Only 5 of the 18 proteins in this list 
were differentially expressed and found in both samples allowing a fold change to be 
calculated. Nearly half, 7 of 18, were found to be expressed within a fold change of 1.5 in 
each sample. 
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Reversed-Phase Pre-Fractionation 
Differential Protein Regulation Relative to WT 
Fold 
Change 
ANXA1 Up Regulated dKO Only 
ANXA6 Up Regulated dKO Only 
ANXA8 Up Regulated dKO Only 
MYH9 Down Regulated 3.1 
Q3UH59 Down Regulated WT Only 
CTNB1 No Difference - 
TBB3 Down Regulated WT Only 
TBB6 Down Regulated WT Only 
TBB2C Down Regulated 2.3 
TBB5 Down Regulated 1.6 
COF1 Down Regulated WT Only 
CALD1 Down Regulated 2.1 
Table 5-4. For the reversed-phase pre-fractionation, there were fewer proteins identified that 
are known to interact with the beta-arrestin proteins. There were a few differences between 
this data and that from the anion-exchange pre-fractionation data as fold changes were 
calculated for some of the tubulin proteins (TBB“X”), which was not previously observed. 
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Figure 5-3. The intact protein pre-fractionation of a MEF cell lysate by anion exchange 
chromatography with UV detection. A BioSuite Q SAX column was used for the separation. 
For both the wild type and double-knockout samples, 2.5 mg of protein were injected on 
column.  A gradient of 25-1000 mM ammonium acetate at pH 9.0 over 60 minutes was used 
for elution of the proteins. The column was operated at the maximum manufacturer 
recommended temperature. Forty fractions were collected from four to 84 minutes. Each of 
the 40 fractions was subject to a trypsin digestion and ran by UPLC-MSE. 
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Figure 5-4. The intact protein pre-fractionation by reversed-phase chromatography with UV 
detection. An Agilent PLRP-S 4.6mm x 30 cm was used for the separation. Mobile phase B 
was comprised of 50% acetonitrile and 50% isopropanol with 0.2% TFA. Mobile phase A 
was 90% water and 10% mobile phase B with 0.2% TFA. The maximum temperature of a 
PLRP-S column is 200°C, however 80°C was determined sufficient for the elution of 
proteins. The appearance of the chromatograms for the two samples is more similar than in 
the anion-exchange pre-fractionation. A total of 54, minute-wide fractions were taken and 
combined to form 18, three-minute wide fractions, which were subject to a trypsin digestion 
and analyzed by UPLC-MSE. 
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Figure 5-6. A pressure trace using arbitrary units was obtained during the intact protein pre-
fractionation utilizing the reversed-phase method. The use of formic acid was necessary to 
reduce the backpressure not only during the run, but also for subsequent runs. Without formic 
acid, the baseline pressure would continue to rise with each subsequent sample injection. 
With formic acid, after an initial spike in the pressure, the sample runs and blank runs were 
nearly identical. 
 
 
 
 
 
 
 
 
 
 196
 
Figure 5-7. The use of formic acid in the injection also had an effect on the data observed in 
the UV trace. The peak at 33 minutes is noticeably absent from the injection without formic 
acid. Additionally, greater signal intensity was observed when formic acid was used.  
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Figure 5-8. A histogram showing the number of fractions a given protein was identified in is 
shown for the anion-exchange pre-fractionation method. By fractionating the gradient 40 
times, there were a substantial number of proteins split across two or more fractions. Data for 
both the wild-type and double-knockout samples are included in this figure. 
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Figure 5-9. A histogram showing the number of fractions a given protein is identified in is 
shown for the reversed-phase pre-fractionation method. By only fractionating the gradient 18 
times, an overwhelming majority of the proteins identified by this method were found in only 
one fraction. Data for both the wild-type and double-knockout samples are included in this 
figure. 
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Figure 5-10. The number of total proteins identified in a single fraction as well as the number 
of unique proteins per fraction is shown for the reversed-phase method. For the unique 
protein data, a protein was only counted in the fraction in which it eluted with the greatest 
number of spectral counts as determined by Scaffold 3.3. As with the anion-exchange pre-
fractionation, little information in the form of new identifications was made in the later 
fractions as compared to earlier fractions. For the reversed-phase method, proteins were 
generally better retained and there were not a substantial number of proteins eluting in the 
dead volume. Data for both the wild-type and double-knockout samples are included in this 
figure. 
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Figure 5-11. The number of total proteins identified in a single fraction as well as the number 
of unique proteins per fraction is shown for the anion-exchange method. For the unique 
protein data, a protein was only counted in the fraction in which it eluted with the greatest 
number of spectral counts as determined by Scaffold 3.3. While many proteins were being 
identified in the last several fractions, little new information was gained as little new 
identification were made in these fractions.  There are also a significant number of protein 
identifications at the dead volume indicating there are many proteins that are unretained by 
anion-exchange chromatography. Data for both the wild-type and double-knockout samples 
are included in this figure. 
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